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Abstract 
Collaborative community-university partnerships are an ethical approach to conduct 
research with Aboriginal and Torres Strait Islanders, to achieve outcomes relevant to these 
communities. In 2016, a research project was conducted in collaboration with, and directed 
by, the Yirralka Miyalk (Women’s) Rangers (YMR) of Laynhapuy Homelands, Arnhem Land, 
Northern Territory, Australia and the National Institute of Complementary Medicine (NICM) 
at Western Sydney University. As a continuation of this collaboration, the research 
documented in this thesis investigates the bush products manufactured by YMR and the 
related traditional medicinal plants used to produce them- Eucalyptus tetrodonta, Melaleuca 
dealbata and Litsea glutinosa through a mixed method research strategy.  
Apart of the participatory action research and community-university partnerships framework 
adopted for this research, semi-structured interviews and focus groups were conducted with 
YMR members and Laynhapuy staff to identify focus areas for further study. The medicinal 
and therapeutic value of E. tetrodonta, M. dealbata and L. glutinosa were identified as areas 
of interest and guided the subsequent research reported in this thesis. To assess the 
medicinal and therapeutic value of the three species, qualitative, semi-quantitative and 
quantitative methods were employed.  
Initially, a systematic literature review was conducted of each plant with records obtained 
from electronic databases and library catalogues. Records obtained were assessed by 
predetermined inclusion and exclusion criteria, with remaining records summarised for 
ethnobotanical, ethnomedicinal, phytochemical and pharmacological activity. To the best of 
knowledge of the author, these are the first systematic reviews to be reported for 
E. tetrodonta and M. dealbata, and although L. glutinosa has been reviewed previously, this 
is the first to report their ethnomedicinal use in an Australian context. 
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Aqueous (aq.) and 70 % aqueous ethanol (aq. ethanol) extracts were prepared from the 
leaves of E. tetrodonta, M. dealbata, and L. glutinosa, with the resulting powder used to 
assess the antimicrobial and anti-inflammatory activity of each plant extract. The 
antimicrobial activity was evaluated against bacterium Pseudomonas aeruginosa and fungus 
Candida albicans by microdilution turbidity and resazurin colourmetric assays. Results 
showed all extracts to possess antibacterial activity (IC60 and IC80) against P. aeruginosa, 
however, the aq. and aq. ethanol extracts of E. tetrodonta possessed the only antifungal 
activity (IC80) against C. albicans (250 µg/mL). Furthermore, the aq. and aq. ethanol extracts 
of E. tetrodonta possessed the greatest anti-inflammatory activity, 72.35 µg/mL and 67.59 
µg/mL, respectively, when assessed by a reduction of nitric oxide production in LPS-
stimulated RAW 254.7 cells.   
E. tetrodonta was also fractionated into six fractions to determine the chemistry responsible 
for the antimicrobial activity, and variances in composition correlating to activity were 
observed. E. tetrodonta was further assessed for solvent extraction composition variances 
using combinations of ethanol/water and isopropanol/water and minimal variances occurred. 
All three plants and their aqueous ethanol extracts were subjected to forced degradation 
studies and it was determined that the greatest changes occurred under acidic and alkaline 
conditions.  
Through the observations made in this thesis, and through continued collaboration following 
participatory action research (PAR) frameworks and mixed method research, it is hoped that 
the scientific evidence gained will continue to support the YMR members and their bush 
products.  
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Chapter 1 Introduction 
___________________________________________________________________________ 
This chapter presents an overview of the work in this thesis. It outlines the background for the 
work, as well as the aims of the research. 
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1.1 Introduction 
Indigenous Australians have inhabited Australia for over 60,000 years (Pascoe and Australian 
Institute of Aboriginal and Torres Strait Islander Studies, 2012) and in this time formed strong 
connections to their natural surroundings. Native flora has a significant role in all facets of 
Indigenous culture and are used as symbolic tools in ceremonies, as art and weapons material, 
decorations, ecological calendars, food sources and natural medicines (Yunupingu et al., 
1994). Regrettably, as the population of non-Indigenous people increased after the 
colonisation of Australia and Western governance dominated, many Aboriginal and Torres 
Strait Islanders moved (or were forced) away from their homelands. As a result, Indigenous 
Biocultural Knowledge (IBK) is at risk of being lost altogether due to the lack of transmission 
of knowledge to younger generations by Indigenous custodians. In recognition of this, there 
is a priority among many Indigenous (and non-Indigenous) groups to preserve Indigenous 
heritage through documentation of their knowledge and practices, often in collaboration 
with state and federal governments, universities and world organisations. 
In the last ten years, changes to federal policy have reflected the global lead for responsible 
change and recognition of traditional medicine and practices for Indigenous populations and 
its preservation. In 2008, participants of the World Health Organisation Congress on 
traditional medicine, including Australia, signed the ‘Beijing Declaration’ (World Health 
Organisation Congress, 2008) committing to respect, preserve, promote and communicate 
the knowledge of traditional medicine, treatments and practices of Indigenous people. 
Australia agreed with these outcomes which have been reflected recently within the 
Implementation Plan for the National Aboriginal and Torres Strait Island Health Plan: 2013-
2023 (Department of Health, 2015). Under the ‘Healthy Adults’ domain- by using cultural 
skills and knowledge including traditional medicines and healing practices, Indigenous adults 
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would be “active contributors to the social and economic development of their families and 
communities” (pg. 28) thus promoting positive health outcomes for Indigenous individuals 
and communities. 
1.2 Project background 
The Yirralka Miyalk Rangers (YMR) belonging to the Yolngu people of the Laynhapuy 
Homelands, Arnhem Land, NT (Figure 1a) are proactive in land management using cross 
cultural practices (Ens et al., 2015), have an established and renowned art scene (Jones et al., 
2009), and have recently (since 2011) developed and manufactured a range of personal care 
products (Figure 1b). These products utilise three culturally significant plants including 
Eucalyptus tetrodonta, Melaleuca dealbata and Litsea glutinosa, and supply an already 
established market locally and nationally (Yirralka Miyalk Rangers, 2011). Through this 
Figure 1 (A) Map of Yirrkala, the homelands of the Yirralka Miyalk Rangers (YMR) in Arnhem Land, 
Northern Territory, Australia. (Google, 2015) and (B) images of Miyalk Bush Products produced 
by the YMR (images: author). 
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growth, however, there is a desire to improve the extraction conditions and quality of their 
products through collaborative research and existing relationships.  
Collaborative opportunities between Western science and Indigenous knowledge provide 
avenues to facilitate networking, data analysis and strategic and policy development (Pert et 
al., 2015), however there is still a desire by Indigenous and non-indigenous leaders for 
independent and sustainable projects run by Indigenous communities, generated by and for 
the community (Rist et al., 2011 and Van der Ploeg and Long, 1994, cited in Ens et al., 2015). 
Examples of these can be seen in various communities across Australia, such as those by 
Palyalatju Maparna Health Committee and Jarlmadangah Burru Community of northern WA 
(Nackee, 2011), the Utopia Homelands community of central Australia (Woods, 2015) and of 
particular interest to this project, the Laynhapuy Homelands community of north east 
Arnhem Land, NT.  
This MRes project builds on long standing existing relationships of Dr Emilie Ens (co-
supervisor) and has been initiated by a desire of the YMR to investigate the medicinal value 
of plants used in their bush products. The relationship with the National Institute of 
Complementary Medicine (NICM) has been initiated through a recent pilot study funded by 
a Western Sydney University grant awarded to Dr Joanne Packer (supervisor) and conducted 
at the NICM herbal analysis laboratory (HAPL), by BV and thus formed the basis of this MRes 
project. Data from this pilot found that the aqueous (aq.) and/or 70% aq. ethanol extracts of 
E. tetrodonta, M. dealbata and L. glutinosa possessed some antibacterial and/or antioxidant 
activity. The phytochemistry of these extracts was also analysed by reverse phase high 
performance liquid chromatography (HPLC) using photo diode array (PDA) detection. This 
method demonstrated the variability in compound profiles of the extraction methods by 
observable differences in their fingerprint chromatograms. 
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1.3 Aims of this project 
The overall objective of this study was to investigate the medicinal and therapeutic potential 
of the YMR bush products and the traditional medicinal plants used in their manufacture. 
Directed by a collaborative partnership between the YMR of the Laynhapuy Homelands 
Aboriginal Corporation and Western Sydney University researchers and their collaborators, 
this thesis aims to: 
 Engage with YMR members to determine relevant investigations of E. tetrodonta, M. 
dealbata and L. glutinosa relevant to their needs and that of the YMR bush products 
enterprise.  
 Conduct a systematic literature review of the three traditional medicinal plants E. 
tetrodonta, M. dealbata and L. glutinosa used in the bush products to determine 
their therapeutic potential. 
 Undertake laboratory experimentation to gain insight into the medicinal value of the 
three traditional medicinal plants: E. tetrodonta, M. dealbata and L. glutinosa. 
 Investigate the optimisation of E. tetrodonta, M. dealbata and L. glutinosa extracts 
for use in the YMR bush products   
Chapter 2 describes the methods used to engage with YMR members to determine the 
direction of this thesis. Chapter 3 deals with the systematic review and in vitro antimicrobial 
and anti-inflammatory activity of the three plants E. tetrodonta, M. dealbata and L. glutinosa 
in relation to their medicinal value. Chapter 4 introduces the first phase of antimicrobial-
guided fractionation of E. tetrodonta in determining phytochemistry responsible for 
observed antimicrobial activity and optimal ethanol:water or isopropanol:water 
combinations for their extractions. Additionally, chapter 5 looks at the conditions that can 
contribute to the degradation of E. tetrodonta, M. dealbata and L. glutinosa extracts.  
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Chapter 2 Community engagement and 
partnership 
___________________________________________________________________________ 
This chapter summarises the Community-University partnership framework, participatory 
action research and mixed methods approach used to conduct the collaborative partnership 
with the Yirralka Miyalk Rangers (YMR) of the Yolngu Indigenous People of Arnhem Land, 
Northern Territory, Australia, and outlines the methods used to direct the investigation of the 
bush products manufactured by, YMRAustralia, and associated traditional medicinal plants 
in this thesis.  
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2.1 Introduction 
The research, upon which this thesis is built, is directed by a collaborative Community-
University partnership with the Yirralka Miyalk Rangers (YMR) of the Laynhapuy Aboriginal 
Homelands Corporations and Western Sydney University. It builds upon preliminary work 
conducted with the YMR members in the investigation of their bush products and relating 
traditional medicinal plants E. tetrodonta, M. dealbata and L. glutinosa. For the best 
outcomes for the Community, this thesis employs a mixed methodology incorporating 
participatory action research (PAR). Furthermore, this ongoing project is governed by 
contractual agreements between YMR and WSU, guaranteeing that all outcomes of this 
collaboration are retained by the Community, and that production methods and product 
information are kept confidential. By having these agreements in place, all partners can 
identify common visions and goals, and clarify their expectations of the outcomes of the 
project.  
2.1.1 PAR and community-university partnerships frameworks for community research 
PAR is represented within mixed methods as well as community-university partnerships and 
can therefore be described as both a methodology and a framework to guide research with 
Indigenous communities (Lawson et al., 2015). Similar to community-university partnerships 
(Suarez-Bakcazar et al., 2004), there are convergent principles common to both. 
“Ultimately, participatory research is about respecting and understanding the people with 
whom and for whom researchers work. It is about developing a realisation that local people 
are knowledgeable and that they, together with researchers, can work towards analyses and 
solutions. It involves recognising the rights of those whom research concerns, enabling 
people to set their own agenda for research and development and so giving them ownership 
over the process.” (Cornwall and Jewkes, 1995). 
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Historically, research within Indigenous contexts has progressed in one direction, with 
academic researchers developing research projects with minimal (if any) input from the 
Aboriginal people or communities involved (Drahota et al., 2016; Jackson-Barrett et al., 2015). 
In the iterative, recursive process and ‘real world’ setting of PAR (Lawson et al., 2015), all 
participants are equal members who endeavour to achieve a common, diplomatically chosen 
aim and contribute towards reaching that goal (Suarez-Bakcazar et al., 2004). PAR as a 
method for community research increases the power of Indigenous people in decision-
making and benefit sharing (Baum et al., 2006). Additionally, community-academic directives 
advocate for enhanced participation of Aboriginal and Torres Strait Islanders in research 
which impacts them to strengthen collaborative relationships, and build more inclusive and 
culturally respectful research.  
This is best summarised by Suarez-Bakcazar et al. (2004), who lists ten characteristics  for 
building and sustaining mutually beneficial and truly collaborative community-university 
partnerships. These include: 
 Develop a relationship built on trust and mutual respect 
 Respect and celebrate diversity, and be aware of culturally sensitive and appropriate 
protocols and methods 
 Recognise and value that all partners in the collaboration can contribute to the 
partnership 
 Acknowledge that all partners have knowledge that can complement each other and 
bring greater understanding to the project  
 Establish open lines of communication and frequent correspondence  
 Learn about the culture of the community organisation 
 Acknowledge that the research collaboration is based on needs of the community 
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 Understand the multidisciplinary nature of partnerships, that all partners bring their 
own cultural and historical backgrounds, perspectives and experiences.  
 Use both qualitative and quantitative research strategies to provide the research 
with multiple levels of analysis 
 Share accountability of partnership success and opportunities, as well as reflect on 
failures as opportunities to learn 
These characteristics supplement the Guidelines for Ethical Research in Australian 
Indigenous studies (Australian Institute of Aboriginal and Torres Strait Islander Studies, 2012), 
which themselves are based on the United Nations Declaration of Rights for Indigenous 
People, recognising that all participants are equal partners in the research collaboration 
(United Nations General Assembly, 2008).  
2.1.2 Mixed method design and PAR 
One principle of community-academic partnerships outlined by Suarez-Bakcazar et al. (2004) 
recommends the use of mixed method research strategies to provide multiple levels of 
analysis. As articulated by Creswell (2015), the core assumption of the mixed methods 
approach, is for a researcher to combine quantitative data with real experience, so that 
together, they provide a greater understanding of the research question than either form of 
data could do alone.  This assumption correlates with the core principles of both PAR 
methodology and the ethical frameworks for research with Aboriginal and Torres Strait 
Islander peoples (Australian Institute of Aboriginal and Torres Strait Islander Studies, 2012; 
National Health & Medical Research Council (Australia), 2003). Personal involvement in 
research strengthens outcomes for Indigenous individuals and their communities, but also 
informs purposeful research.  
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PAR is a form of action research (AR) which sets out to engage with people, conduct research 
and improve a system simultaneously by acknowledging locally defined aims and outcomes 
(Baum et al., 2006; Cornwall and Jewkes, 1995). The PAR method is an iterative cycle (Figure 
2) of planning, doing, studying and acting, with an additional distinctive phase of reflection 
to determine steps to progress forward (Lawson et al., 2015). For academic-community 
partnerships, this approach ensures that all partners remain equal contributors and are 
involved at all stages throughout the research, thus making it an appropriate method for 
community engagement.  
2.1.3 Engagement with YMR members and semi-structured interviews as a method for 
collaboration  
It is imperative to conduct ethical Indigenous research that values equally all participants, 
their ideas and contributions. Existing congruent guidelines from (Australian Institute of 
Aboriginal and Torres Strait Islander Studies, 2012) and (National Health & Medical Research 
Council (Australia), 2003), both value the full participation and engagement of Aboriginal and 
Torres Strait Islander people in research. 
Figure 2 The iterative PAR cycle. Over time, the PAR cycle is undergoing a continual process of 
planning, doing, acting and reflecting. The qualitative/quantitative method chosen for each stage can 
be done individually or complementary to each other, with the results and the outcomes unpredicted, 
only that it will follow another PAR cycle. 
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In contrast to traditional collaborations, initiated by researchers who approach communities, 
this collaboration was initiated by YMR members. It was built upon informal discussion held 
in Yirrkala, NT between YMR members, trusted community liaison Dr Emilie Ens and invited 
researchers JP and BV. In these discussions, knowledge was exchanged and YMR members 
articulated their aims for their bush products enterprise. These included the desire to gain 
scientific evidence regarding the medicinal value of E. tetrodonta, M. dealbata and L. 
glutinosa including their optimisation and manufacturing. Plant material was provided and a 
preliminary laboratory screening was conducted in October 2015 on the bush products and 
their associated plants E. tetrodonta, M. dealbata and L. glutinosa. To continue to build a 
trusting relationship, YMR members were invited by researchers to the NICM laboratories to 
learn about the methods and better understand the plants used in their bush products. 
Through these reciprocal visits, a collaborative relationship was initiated.  
To continue a mutually respectful and trusting relationship, it was essential that YMR 
members continued as equal partners in the collaboration but still retained ownership over 
the outcomes of the project. It was also necessary that governance of the bush products was 
retained by YMR members and that all decisions were transparent and therefore continued 
to build trust within the partnership. To ensure that this was maintained, semi-structured 
interviews and focus groups were employed as a tool for dialogue between researchers and 
community. As described by (Dicicco-Bloom and Crabtree, 2006), key features of semi-
structured interviews which make it an ideal method for collaborative projects is that they 
are organised around a set of predetermined questions and through dialogue, other 
questions can emerge. They enable researchers to explore the views and opinions of 
participants that can be sensitive in nature, and get clarification as required, without 
introducing bias (Barriball and While, 1994). The predetermined questions of semi-structured 
interviews and focus groups are not generally identical between interview participants. This 
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is advantageous when conducting interviews with Aboriginal and Torres Strait Islanders 
whose first language may not be English because it allows for varied language and vocabulary 
whilst still maintaining the meaning. This method takes into consideration that participants 
may not interpret the same meaning to words as other participants (Irvine et al., 2013). As 
expressed by (Barriball and While, 1994), it is the “equivalence of meaning” that ensures that 
semi-structured interviews are standardised, and through such a method, the research 
process avoids bias and errors (Barriball and While, 1994). This thereby supports 
collaborative research with communities because it ensures that the directions for research, 
and thus, the outcomes, remain credible and reflective of community goals.  
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2.2 Methodology 
2.2.1 Research Approvals 
This research was carried out in partnership with YMR members and was governed under 
corporative and confidential research agreements (Appendix I) between NICM at Western 
Sydney University (WSU) and the YMR and Laynhapuy Homelands Aboriginal Corporation. In 
May 2016, semi-structured interviews and focus groups were conducted at Yirrkala and 
Dhalinybuy Homelands in North-East Arnhem Land, Northern Territory. The format and 
content was approved by the WSU Human Research Ethics Committee (HREC) prior to the 
interviews (approval number H16220; Appendix II) and permission to be on Aboriginal Land 
was sought from the Northern Land Council (Permit ID 62521; Appendix III).  
2.2.2 Semi-structured interviews and focus groups 
On invitation from YMR members, researcher BV, travelled to Yirrkala in May, 2016 for 4 days, 
to meet with the Rangers and Laynhapuy Aboriginal Homelands Corporation staff to gain 
insight and direction for the project. Participants involved (in any capacity) with the YMR 
bush products project were invited to participate and give their input to the project via the 
semi-structured interviews and focus groups process. Prior to the researcher’s visit, the 
cohort was approached by EE, chosen purposively and at non-random. The questions were 
developed in consultation with the YMR group and Laynhapuy Homelands administrative 
support and provided to prospective participants prior to interviews (Appendix IV). The 
questions were accompanied by participant information and consent (PIC) sheet (Appendix 
V) explaining that their participation was voluntary and that they could withdraw from the 
study at any time. Additionally, the PIC also outlined how the interviews would be conducted 
and by whom; the questions which would be asked and how they would be recorded; how 
the information gained would be handled and used; and who would have access to it at the 
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conclusion of the study. The information sheet was verbally translated where necessary into 
Yolngu Matha, by Gurrundul Marika (YMR mentor). All participants were asked to sign the 
PIC before the interview commenced indicating they understood their involvement.  
All interviews were conducted by BV over a three-day period, under the supervision of 
Ms Gill Towler, YMR liaison or EE. Participants were given opportunity to express their views 
about the YMR project through three broad open-ended questions- “1) How are you involved 
in the bush products project?”; “2) What did you think of the first part of the bush products 
testing?” and “3) What would you like to see happen next with the bush medicine products?”. 
Qualitative analysis of the data began immediately after the interviews. Summary notes were 
made from the interviews and clarification of terms with GM and EE. Audio records were 
transcribed to English, coded and categorised into themes by BV. 
The interviews and focus groups were conducted by BV under the supervision of EE and/or 
GT and carried out from the 17th-19th May. The data was obtained from two focus groups 
and two interviews that ranged in duration from 15 to 60 minutes. They took place face-to-
face, at the Yirralka Ranger office in Yirrkala, under a tree at Dhalinybuy Homelands and at a 
participant’s home; one interview was conducted over the phone. Interviews and focus 
groups were audio recorded with permission and notes taken at the time by BV. The semi-
structured interviews and focus groups involved seven participants who consented to be 
identifiable; six participants (86%) consented to be audio recorded. Five of the six 
participants - Gurrundul Marika (GMA), Nyemburr Mununggurr (NMU), Gidilpawuy 
Munyarryun (GMU), Bungamana Ganambarr (BGA) and Djurambil Mununggurr (DMU), are 
directly involved in the production, manufacture and selling of the YMR bush products. The 
sixth and additional participant, Dave Preece (DPR) is the Laynhapuy Indigenous Protected 
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Area (IPA) manager and is involved in providing administrative support to the YMR members 
and their bush products enterprise. 
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2.3 Results & Discussion 
Conducting semi-structured interviews and focus groups was an appropriate method to gain 
insight into the perceptions of YMR members of the bush products enterprise as well as the 
collaboration with NICM. Presented with three open-ended questions, participants spoke 
about their pride in their involvement in the YMR bush products as well as improvement of 
the bush products beyond their therapeutic optimisation but in ways that their own skills 
could be used to improve the bush medicines. Additionally, there was a desire to share their 
traditional medicinal plant knowledge and skills in bush product manufacturing with the 
wider community. Though there was a small sample size (n=6), the data did inform future 
directions for the community-university partnership.  
All participants had been involved from the businesses inception in 2011, although none of 
the YMR members defined their positions within the enterprise other than agreeing they 
were involved in all aspects (collecting plant material, processing, manufacturing products 
and selling). Overall, their excitement and enthusiasm to be involved in the bush products 
was evident in their body language. One participant, Gurrundul Marika, began by recalling 
her thoughts when the bush products business started: 
(GMA): “… The Miyalk [Women] Rangers came together and said they wanted to start 
 making bush products. It is very exciting for everyone. For me, I was really, 
 really excited. ” 
The market for complementary medicines in Australia is increasing yearly (Ghosh, 2014), and 
it is the belief by participants that the YMR bush products has potential to be a competitive 
business. There is a desire to build capacity so that production of the bush products can 
increase whilst still keeping the products consistent. Currently, the bush products enterprise 
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is still in a growth phase and there is interest for the business to adapt commercial and/or 
larger scale equipment for extraction and manufacturing of the bush products. The 
commitment to supporting such a task was evident as the “Layna” organisation who were 
eager to support the development of the bush products by purchasing any equipment or 
permits required.  
Presently, the YMR bush products are a cosmeceutical range of rubs, scrubs and soaps; 
however, the participant’s reiterated their desire to manufacturer products that could be 
used to treat sick people. It is well known that Aboriginal and Torres Strait Islanders 
experience a disproportionate burden of disease compared with the general Australian 
population (Australian Institute of Health and Welfare, 2015), with topical skin infections, 
including Staphylococcus aureus and Streptococcus pyogenes co-infections as an emerging 
cause of impetigo, boils, cellulitis and folliculitis infections in the Northern Territory (Bowen 
et al., 2014; Currie and Carapetis, 2000; Marquardt, 2014). These were reflected by 
respondents: 
(DPR): “Boils are a bad condition for the community as well as strep throat which lead s 
 to rheumatic heart disease.” 
It was proposed that illness amongst the community, particularly the elderly, was attributed 
to bad diet, lifestyle choices and not taking prescribed medications as directed. Participants 
felt that by educating the community and health workers about their products and traditional 
medicinal plants, it could help improve the health of their community. Strategies suggested 
included placing informative posters in health clinics about the YMR bush products and 
related traditional medicinal plants, and their therapeutic benefits:  
  
33 
(BGA): “For the bush products, putting it on the front table [in clinic] so that everyone 
 can see what’s in the bush products, because doctors from all over will come to 
 visit the clinic will know about the bush medicines.” 
Furthermore, Bungamana also added: 
(BGA): “visitors can come and they can see, and they can learn from us, and we can 
 share our knowledge, and then they get their medicine from us.” 
Teaching the wider community and sharing their traditional medicinal plant knowledge with 
younger generations was also an important factor for all participants. They envisaged this as 
teaching younger generations through current Learning on Country Yirralka Ranger programs, 
but also working alongside the YMR members in the manufacturing of the YMR bush products:  
(BGA): “For the secondary kids, at the school – learning on country, planted in front of  the 
learning centre, with plants from the nursery.”  
(EE): “You could make the soaps with the kids” 
(BGA): “Yeah that’s my thinking” 
(EE):  “we can make more medicine soap, more bush medicine” 
(BGA): “Yo.”   
Literature emphasises that such programs increase the success of Indigenous enterprises by 
providing hands-on experience and training, as well as access to role models who can provide 
knowledge and skills to support sustainable employment for communities (Shoebridge et al., 
2012). YMR members themselves learnt the skills to manufacture the cosmeceutical range 
through workshops run by a “bush products Miyalk [woman]” from the organisation, Bush 
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Traders, and as they feel they are getting older, are wanting to share the bush products 
knowledge (i.e. business and manufacturing skills) with younger members of the community, 
who will then be able to continue the business in later years.  
The manufacturing methods have overtime been modified and adapted by the YMR from the 
methods which were taught to them, towards methods that were closely aligned with their 
envisaged outcomes:  
(GMA): “in the beginning it was a little bit different because we still learning…tried lemon 
 scented oil, and then bought Nambarra [tea tree oil] and used that, and then 
 moved from using bought to using natural.” 
Although the current manufacturing methods have remained the “same way for a long time”, 
there was an overall consensus that members had become bored with the process and that 
the products could be improved and “made nice”. For some, to improve the quality of the 
products, they would like to “…learn some more from the bush traders...”, but also, in return 
show the bush traders and other community Rangers how they have modified and adapted 
their methods to align to their needs.  
All YMR members mentioned the packaging of the products needed improvement:  
(BGA): “the packaging is boring, not nice, make the package and shape nice, and have  the 
 name on it, on the top. More eye catching. Keep it interesting.” 
They felt that the name of the product should be better placed, so that consumers can 
identify the plant used to make the bush medicine, with others also wanting to include 
additional information such as the cultural heritage and significance of the plants in 
additional tags, or documents sold with the products. Others were interested in 
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incorporating natural dyes to colour the soaps, or present the bush products on weaved 
baskets, as was shown by Gidilpawuy. Gurrundul told us of her connectedness to the plants 
used in the bush medicines products, and how these could be reflected in the packaging: 
(GMA): “Gadayka [E. tetrodonta] is my grandmother’s mother, connected, linked and 
 related, all strong connection, both Duwa… they have song lines, and paintings, 
 put songlines on packaging with the products of Nambarra [M. dealbata] and 
 Gadyaka so everyone can understand and learn about where it’s from.” 
Participants were also enthusiastic to expand their marketing to include “Facebook and 
Youtube” and use this medium to further share with consumers their connection to these 
culturally significant plants. 
Currently, manufacturing is conducted at the Yirralka Rangers office in Yirrkala, however 
members expressed that they preferred other locations for “djama [work]”. It was desired 
by all, that additional sites for manufacturing be included:  
(DMU): “Much better out here [Dhalinybuy] than doing it in the office.” 
The YMR members also suggested that by moving production to other sites, there was an 
opportunity for different communities to produce different products: 
(DMU): “we could do it here, have different in different communities.” 
As mentioned by participants the current plants being tested by NICM have other traditional 
medicinal uses which YMR members are interested to explore further.  Nyemburr 
Mununggurr mentioned that Gadayka (E. tetrodonta) was used in traditional smoking 
ceremonies to improve health and make “them strong”. YMR members understood that by 
igniting the plant material, oils were released and thus suggested that a Gadayka product like 
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a “baby oil- oil for people” could be produced using this plant.  Gurrundul, Nyemburr and 
Gidilpawuy also suggested “Nambarra” (M. dealbata) should be used as a “chest rub”, 
reflective of its traditional use by the community. Questions of the therapeutic potential of 
the products were also explored by the participants and it was articulated that a future bush 
medicine product should have a topical delivery:  
(BV): “make it more like a medicine?” 
(BGA):  “Yeah, like a cream.” 
In addition to the three originally identified plants of interest to this research (Gadayka, 
Nambarra and Butjiringaning), additional plants were identified by YMR members as 
additional sources for bush medicines products. Additionally, Djurambil expanded on this and 
talked about their use as “bush tucker”. 
In summary, participants, who were all involved in the enterprise and manufacture of the 
bush products, all indicated the collaboration between YMR and WSU would enable the YMR 
to optimise the current products and enhance their therapeutic applications. Participants 
had views for the growth of the YMR bush products enterprise that were common amongst 
the group. It was a priority to share plant and bush medicine knowledge with members of 
the community, as well as with health care workers and tourists alike. There was desire to 
grow the business through marketing and updating packaging to reflect their culture as well 
as move manufacturing to additional communities such as Yilpara, Gangan, Dhalinbuy and 
Garrthalala, in addition to the Yirralka Rangers office in Yirrkala. Furthermore, areas were 
identified that could be supported through the Community-University partnership including 
the investigation of E. tetrodonta “Gadayka” as a potential antibacterial or antifungal 
therapeutic topical cream.  
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2.4 Conclusions 
Collaborations between communities and researchers must respect Indigenous governance 
and ensure all participants are given equitable recognition of their contributions to the 
research. By including YMR members in all aspects of the research and collaboration, it 
ensures that the outcomes of the research are relevant to their needs, and reflect their 
desires for the YMR bush products enterprise.  
The purpose of the semi-structured interviews and focus groups was to identify the YMR 
members views and desires for the future direction of the community-academic partnership. 
This method provided a suitable avenue for all members to have an equitable contribution 
to the future stages of the project and ensured that all academic research was conducted 
with the interests of the members as the primary focus. As a result of the interviews, Gadayka 
(E. tetrodonta) was identified as a plant of primary interest for future therapeutic research, 
in addition to continued study of Nambarra (M. dealbata) and Butjiringaning (L. glutinosa).  
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Chapter 3 Systematic literature review 
of E. tetrodonta, M. dealbata and 
L. glutinosa and a study of their 
bioactivity 
___________________________________________________________________________ 
This chapter presents a mixed methods approach to appraise three medicinal plants- 
Eucalyptus tetrodonta, Melaleuca dealbata and Litsea glutinosa used in the manufacturing 
of the YMR bush products, by conducting a systematic literature review and in vitro 
antimicrobial and anti-inflammatory screening, with combined results used to assess their 
medicinal value. 
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3.1 Introduction 
Australia is home to the oldest Indigenous population on Earth (Veth and O'Connor, 2013) 
with Aboriginal and Torres Strait Islander people having survived as the original inhabitants 
of Australia for over 60,000 years (Pascoe and Australian Institute of Aboriginal and Torres 
Strait Islander Studies, 2012). In this time, they have formed strong connections with their 
natural surroundings, evident in the significant role Australian flora has in all facets of 
Indigenous culture and lifestyle. Flora is intertwined in their everyday life and is used as 
symbolic tools in ceremonies, as art and weapons material, decorations, ecological calendars, 
food sources, as well as medicines for healthcare and general wellbeing (Barr et al., 1988). 
Recognised as a biologically megadiverse continent, Australia’s long isolation has also 
supported a diverse flora, of which 85% is endemic to the Australian continent (Australian 
State of the Environment Committee, 2001; Common and Tony, 1992; Mummery and Hardy, 
1994). The Arnhem Coast, one of the eighty-nine bioregions of Australia, is a unique 
assortment of ecoregions comprised of coastal heathlands, mangroves, saline flats and 
coastal dune systems as well as tall open Eucalypt forests, monsoon rainforests and Eucalypt 
woodlands (Commonwealth of Australia, 2012). In contrast to other Indigenous communities 
who have lost or been at risk of losing their medicinal plant knowledge due to displacement 
from homelands, degradation of habitat and unsustainable exploitation of resources 
(Australian State of the Environment Committee, 2001; Boll, 2006; Kingsley et al., 2013; Rigby 
et al., 2011; Rusack et al., 2011; Stocker et al., 2016), the Arnhem coast is protected under 
declared Laynhapuy Indigenous Protected Area (IPA) agreement, declared in 2006 with the 
Australian Government, and managed locally by the Yolngu Indigenous peoples of Northeast 
Arnhem. With a unique combination of ecosystem, as well as Indigenous expertise in land 
management practices (Yibarbuk et al., 2001), the Indigenous peoples of Arnhem Land are 
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protecting and securing culturally valuable medicinal plant knowledge for future generations. 
For the remote Indigenous communities, this knowledge and the dynamic combination of 
traditional and contemporary medicinal practices (Gaikwad et al., 2011; Packer et al., 2012) 
presents Indigenous peoples with a significant cultural, medicinal and economic resource, 
especially for the communities of Northeast Arnhem.  
Indigenous knowledge through symbols and artworks are highly valued resources to society 
(Jones et al., 2009), and as an extension of this the value of documentation to record and 
preserve knowledge should be afforded the same importance. In the past, documentation of 
Indigenous medicinal knowledge of traditional plant species has contributed a number of 
vital modern drugs (Dias et al., 2002) and to ensure the equitable acknowledgement of all 
partners in collaboration, it is important that Indigenous ethnomedicinal knowledge is 
recorded.  
3.1.1 Plant background of E. tetrodonta, M. dealbata and L. glutinosa 
E. tetrodonta, M. dealbata and L. glutinosa are used in the manufacture of the YMR bush 
products. E. tetrodonta from the family Myrtaceae, is a common and widespread evergreen 
species found across the north of Australia, from North Eastern QLD to the northern Kimberly 
of Western Australia (Bean, 2006; Prior et al., 2004). These trees grow 10-20 metres tall, with 
fibrous to stringy grey bark distinctive of the species and giving rise to the common name 
“Darwin Stringybark”. M. dealbata, also from the family Myrtaceae, is an evergreen tree with 
a similar distribution as E. tetrodonta (Brown et al., 2001), although it can also be found in 
South-East Asia (Turnbull and Lea, 2016). Its common name is “Blue Paperbark”, referring to 
the blue-grey foliage of its branches, and papery and layered bark. From the family Lauraceae, 
L. glutinosa is the most widely distributed of the three trees, found in the tropical rainforests 
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of north Queensland and Northern Territory of Australia as well as India, China and south-
east Asia (Centre for Australian National Biodiversity Research, 2010).    
3.1.2 Previous bioactivity screening of E. tetrodonta, M. dealbata and L. glutinosa 
The bioactivity study performed here follows a preliminary study documenting the 
antimicrobial activity of E. tetrodonta, M. dealbata and L. glutinosa aq. and aq. ethanol leaf 
extracts against gram positive bacteria S. aureus (ATCC® 25923) and S. pyogenes 
(ATCC® 19615) (unpublished report). The antimicrobial activity was determined by disc 
diffusion, turbidity, resazurin and bactericidal/static assays. The aq. ethanol extracts of 
E. tetrodonta and M. dealbata inhibited S. aureus at 500 µg/ml, whereas S. pyogenes was 
inhibited by the aq. ethanol leaf extracts of E. tetrodonta (1000 µg/ml) and L. glutinosa 
(1000 µg/ml). Additionally, at the same concentrations, these extracts also showed 
bactericidal activity against the microbe tested. Overall, results demonstrated that these 
gram positive bacteria were more susceptible to the aq. ethanol extracts of each plant than 
their aq. counterparts. 
The plant extracts were also assessed for their in vitro DPPH antioxidant scavenging ability. 
Scavenging activity was determined as an equivalence of gallic acid (GAE), and results showed 
that the aq. extracts of E. tetrodonta (315 µg GAE/mg extract) and M. dealbata 
(205 µg GAE/mg extract) had the greatest antioxidant activity of the extracts. The aq. extract 
(18.3 µg GAE/mg extract) and aq. ethanol extract (58.4 µg GAE/mg extract) of L. glutinosa 
had the least antioxidant scavenging activity.    
3.1.3 Mixed methods for the evaluation of the medicinal value of traditional plants 
A mixed method approach has been adopted to elucidate the medicinal value of 
E. tetrodonta, M. dealbata and L. glutinosa. As expressed by other authors, a combination of 
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qualitative and quantitative methods can provide a holistic view of the research question and 
provide an outcome with a better depth of knowledge than is possible with just qualitative 
or quantitative studies (Creswell, 2015; Joanna Briggs Institute, 2008; Pluye and Hong, 2014). 
This is particularly important as evidence gathered through various methods  inform policy 
and practice (Harden, 2010).  
The ethnomedicinal plants of Yirrkala have previously been documented (Yunupingu et al., 
1994), however the data is localised to Yirrkala and does not describe any scientific evidence 
such as laboratory testing. Other publications (Aboriginal Communities of the Northern 
Territory of Australia et al., 1993; Brock and Dunlop, 1993) have summarised ethnomedicinal 
use from many communities and have supplemented this information with biological and 
chemical analysis; however these results, in contrast to present day techniques, provide only 
minimal pharmacological and phytochemical evidence. By reviewing literature using guided 
methods (Moher et al., 2009), articles can be identified, that in combination with laboratory 
screening,  give a more comprehensive understanding about the ethnomedicinal use, 
phytochemical and pharmacological activity associated with traditional medicinal plants. 
Furthermore, this data can comprise a part of the evidence used for the efficacious and safe 
use of ethnomedicinal plants by Indigenous and non-Indigenous consumers. 
It was therefore the objective of this chapter to conduct a mixed methods study of the three 
plants used in the YMR bush products: Gadayka (E. tetrodonta), Nambarra (M. dealbata) and 
Butjiringaning (L. glutinosa), and determine their medicinal value through a systematic 
literature review, antimicrobial screening and in vitro anti-inflammatory activity.  
 Systematic literature review of E. tetrodonta, M. dealbata and L. glutinosa 
“Gathering research, getting rid of rubbish and summarising the best of what remains 
captures the essence of the science of systematic reviews.” (Grant and Booth, 2009) 
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Systematic literature reviews retrieve, appraise and summarise all of the available evidence 
to establish whether findings are consistent between different studies, and if so, what 
generalisation and conclusions can be distilled to answer the review question (Mulrow, 1994; 
White and Schmidt, 2005). Furthermore, conducting the systematic literature review method 
appraises the quality of the research, synthesises research evidence, identifies gaps and 
prevents duplication of research (Popay et al., 1998). This type of qualitative method is 
preferred in comparison to other methods such as a literature review, as a systematic 
literature review follows a series of steps (e.g. PICOS or PRISMA guidelines) that minimise 
reviewer bias with detailed methodology for others to replicate the search process (Grant 
and Booth, 2009).   
 A preliminary scoping review of the three plants E. tetrodonta, M. dealbata and L. glutinosa 
using PRISMA reporting guidelines (Moher et al., 2009) was conducted in October 2015 with 
undergraduate student Elizabeth Morgan [unpublished]. Once a preliminary search strategy 
was conducted of the three plants, L. glutinosa was selected for review as no ethnomedicinal, 
phytochemical and pharmacological reviewed articles were identified. Recently, reviews 
have been published on the traditional use, phytochemistry and pharmacology of the Litsea 
genus (Kong et al., 2015; Wang et al., 2016) and though these included L. glutinosa, neither 
review included information from an Australian context.  
 Antimicrobial and Anti-inflammatory screening of E. tetrodonta, M. dealbata 
and L. glutinosa 
Previous screening results (outlined in in § 3.1.2) suggested that the aq. and aq. ethanol 
extracts of all three plants possessed antimicrobial activity against gram-positive bacteria 
S. aureus (ATCC® 25923) and S. pyogenes (ATCC® 19615), and possessed some antioxidant 
scavenging capacity detected by a DPPH assay.  To determine if the extracts possessed any 
antimicrobial activity against gram-negative bacteria and fungi, the aq. and aq. ethanol 
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extracts of E. tetrodonta, M. dealbata and L. glutinosa were screened against Pseudomonas 
aeruginosa (ATCC® 19615) and fungi Candida albicans (ATCC® 10231). In addition, extracts 
were also screened for their anti-inflammatory activity against stimulated murine RAW264.7 
macrophage cells. 
3.1.3.2.1 Antimicrobial screening methods 
The microdilution methods selected for this chapter were identical to those used in the 
preliminary study. Maintaining consistent methods between studies will make it possible to 
compare the antimicrobial activity of the aq. and aq. ethanol extracts of E. tetrodonta, 
M. dealbata and L. glutinosa. The three methods for assessment of antimicrobial activity are 
conducted sequentially, and include microdilution turbidity, resazurin colourmetric and 
bactericidal/static assays, respectively.  
3.1.3.2.1.1 Microdilution turbidity assay 
In a 96-well plate format, this turbidity assay measures the density of cells 
spectrophotometrically. Cells are treated with various concentrations of sample and
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incubated under optimal growing conditions. After incubation, the change in turbidity is 
determined and compared to the control cells and sterility lanes. The concentration 
inhibiting the growth of cells by 80% (IC80) is then determined. Figure 3 shows a typical plate 
set up. 
Although this method can provide a rapid screening of many extracts, the data can be 
misleading. Though the turbidity measurement is a reflection of the cell density, it does not 
differentiate cell viability. The incubation temperature can also influence turbidity due to an 
evaporation of the media, leading to greater turbidity readings in the wells; this can however 
be overcome by placing an external border on the plate which will reduce ‘edge effects’ to 
the culture.  Additionally, the samples, for example L. glutinosa water extract which are not 
completely soluble in water, precipitate in solution and they themselves can cause turbid 
readings. This can be overcome with the addition of surfactants such as Tween20, or by 
reducing the concentration of sample tested.  
 
Figure 3  Orientation of 96-well plate for microdilution turbidity and resazurin assays.  
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3.1.3.2.1.2 Resazurin colourmetric assay 
In addition to the turbidity assay, resazurin colourmetric assay adds another analysis that 
determines inhibitory concentration through a different mechanism. Resazurin, a non-toxic, 
cell permeable compound is a redox indicator (Sarker et al., 2007), which in the presence of 
viable cells, is reduced to a bright pink fluorescent pigment, resorufin. This pigment can be 
observed visually and can indicate wells with viable cells (Figure 4). So long as the inhibition 
of the microbe behaves in a dose dependent manner, this method can determine the 
minimum concentration of sample that inhibits cells growth.  
Misleading results can occur through this method if there is interaction between the sample 
and the resazurin compound. Crude samples may themselves contain reductants, thereby 
reducing resazurin to resorufin, without the presence of viable cells. One way to overcome 
this is to determine if the sample has reductant potential by combining the plant extract with 
the resazurin solution, without the microbe, under the same experimental conditions.  
3.1.3.2.1.3 Bactericidal/static assay 
A continuation from the turbidity and resazurin assays, bactericidal/static assay determines 
if the treated microbes remain viable (static) or whether treatment with the extract has 
destroyed the microbe completely. To do this, from the wells, an aliquot (4-10 µL) of the 
contents of the well is transferred to a sterile agar plate. After an incubation time, the plate
Figure 4 Example of the colour change due to the reduction of resazurin (blue) in the 
presence of viable cells to resorufin (pink). Sterility lanes are not inoculated with cells. 
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 is inspected for growth. If growth is observed, the sample is said to be bacteriostatic, 
however if no growth is observed, it is bactericidal (Figure 5). The concentration determined 
to be bactericidal is the lowest concentration of test sample to show no growth.  
3.1.3.2.2 Anti-inflammatory screening method 
Inflammation is a fundamental process for human health, and is involved in the defence of 
the body from many injuries and disease. However, chronic inflammation can be a 
contributing factor for many inflammatory diseases including rheumatoid arthritis, 
neurotoxicity and cancer (Zhuang and Wogan, 1997). The six plant extracts were assessed for 
their potential anti-inflammatory activity by an in vitro assay utilising stimulate murine 
RAW264.7 macrophage cells stimulated to release nitric oxide (NO).  
3.1.3.2.2.1 Determination of NO Production 
During an inflammatory response, stimulated macrophage cells release NO. Under 
experimental conditions, murine RAW264.7 macrophage cells are stimulated by 
lipopolysaccharides (LPS), a component found on the outer membrane of gram negative 
bacteria, causing cells to activate and begin to produce free radical NO. Once exposed to 
oxygen, NO is oxidised to nitrite which can be measured from the liquid culture medium by 
the Griess method as an indirect marker of the inflammatory response.  
Figure 5 Representative image of resazurin MIC (left) and corresponding cidal activity (right).  
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Nitrites are measured in the culture medium using the Griess method, which involves a 
colourmetric reaction that is quantified spectrophotometrically. The colourmetric reaction 
involves the diazotization of sulphanilamide by nitrite using Griess reagent under acidic 
conditions. Following diazotization, the resulting diazonium salt is coupled with N-1-napthyl-
etylenediamine (NEDD) to form an azo dye. This azo dye can be quantified based on its 
absorbance at 543 nm. A larger absorbance at 543 nm correlates to a greater presence of 
nitrite in the sample solution. To ensure the absorption is proportional to the quantity of 
nitrite in the solution, NEDD is added in excess to ensure that it does not act as the limiting 
reagent in the reaction. 
3.1.3.2.2.2 Determination of cytotoxicity by MTT 
Cell viability is paramount in the determination of NO production. Murine RAW264.7 
macrophage cells are seeded at the same concentration and are therefore controlled. When 
stimulated and exposed to a test sample that can reduce inflammation, measurable nitrite 
concentration is also reduced and this can be determined as an encouraging indicator of anti-
inflammatory activity. Conversely, the measurable nitrite concentration may be reduced due 
to a reduction of cell numbers due to an adverse, cytotoxic, affect to the cells. To confirm if 
the test sample is indeed anti-inflammatory (or cytotoxic), cell viability is measured by (3-
(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide), or MTT. When introduced to 
viable cells, the tetrazolium ring of MTT is cleaved by mitochondrial dehydrogenase to yield 
MTT formazan. This is observed as a purple precipitate in wells, which can readily be 
dissolved in DMSO for quantification spectrophotometrically at 595 nm. Data is compared to 
untreated-LPS stimulated-control cells and DMSO blank, and cytotoxicity of the test sample 
can be determined.  
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3.2 Methodology 
3.2.1 Systematic reviews 
A systematic review was undertaken of published literature reporting the ethnobotanical, 
ethnomedicinal, pharmacology and phytochemistry of E. tetrodonta, M. dealbata and L. 
glutinosa in accordance with the PRISMA statement guidelines (Moher et al., 2009). 
Comprehensive searches of the literature were conducted through JSTOR, PubMed, 
ScienceDirect, SciFinder and Scopus for studies published prior to 1st October, 2015 for L. 
glutinosa and again before 31st August, 2016 for E. tetrodonta and M. dealbata. Searches 
were conducted independently for E. tetrodonta and M. dealbata and with an additional 
reviewer, Elizabeth Morgan, for a preliminary scoping review of L. glutinosa. 
Common names and synonyms were identified through Australian Plant Name 
Index (https://biodiversity.org.au/nsl/services/apni) and Australian common plant name 
database (https://www.anbg.gov.au/common.names/); if the common name was also a 
synonym for another plant, it was excluded as a key term.  Local vernacular was however 
included for E. tetrodonta, M. dealbata and L. glutinosa- “Gadayka”, “Nambarra” and 
“Butjiringaning”, respectively, as one of the aims of the review was to provide the YMR with 
any literature about the plants used in their bush products.  
The database search strategies are outlined in the Appendix VI. All document types were 
included, with remaining abstracts screened according to inclusion and exclusion criteria 
(Table 1). Articles which met the inclusion criteria were assessed independently, and full texts 
obtained where ever possible.  
Each article was reviewed for traditional use, pharmacology and phytochemistry. The quality 
of the articles was appraised independently by reviewing the methodology and  
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Table 1 Inclusion and exclusion criteria for systematic literature reviews 
Inclusions 
 Able to obtain abstract/full text 
 Abstract/full text available in English or as English translation 
 Information on scientific or common name 
 Information including traditional use, pharmacology and phytochemistry 
 Published peer reviewed 
 Peer-reviewed articles, books and reference manuals 
Exclusions 
 Abstract unavailable 
 Abstract/full text unavailable in English or as English translation 
 Incorrect scientific/common name 
 Article does not articulate species name (i.e. refers to only genus level) 
 Irrelevant data including agriculture, cultivation, growth, metabolism, primary  
metabolism, distribution 
 Unaccepted manuscripts 
 Patents 
reporting of each text. When the full text of an article was not available, in English or as an 
English translation, the abstract was included however; the quality of these articles could not 
be appraised. Articles were excluded if the scientific name was provided only to genus level, 
or did not have relevant data regarding traditional use, pharmacology or phytochemistry. 
Furthermore, patents were also excluded if the full text was unavailable or not in English. 
Any ambiguous articles which could not be resolved independently were resolved through 
discussion with supervisors or the larger research group.   
Data was extracted from included articles and categorised according to their ethnomedicinal 
and ethnobotanical use (including traditional use), pharmacological activity (bioactivity and 
toxicity) and chemistry (phytochemistry and secondary metabolites). Further information 
recorded from included descriptions of key plant features, country of study and local 
vernacular, preparation methods and the experimentation parameters.   
3.2.2 Plant collection and vouchering 
The plant parts were selected due to their traditional use and use in the bush product range 
of soaps, scrubs and rubs produced by the Yirralka Miyalk Rangers (YMR). The plant material 
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was selected, collected and provided to the NICM researchers by the YMR members. Fresh 
plant material was provided in October 2015 and May 2016, each time refrigerated at 4°C in 
sealed bags for transportation.  
Three plants were selected by YMR and provided for laboratory analysis. The leaves of 
E. tetrodonta, M. dealbata and L. glutinosa were provided by YMR members in May (Table 2).  
Table 2 Plant and vouchering details 
Plant Plant part Collection date Voucher No.* 
E. tetrodonta Leaves May 2015 HH1143 
M. dealbata Leaves May 2015 HH1144 
L. glutinosa Leaves(A) May 2015 HH1142 
(*) Index number at CT Musson Herbarium, Index Hawkesburensis; (A) Spines of leaves 
removed. 
Plant specimens were identified by Ms Gill Towler (YMR Ranger Mentor), vouchered and 
deposited at CT Musson Herbarium under Index Hawkesburensis. The identity of M. dealbata 
specimens were further confirmed by Dr. Alison Hewitt (School of Science and Health, 
Western Sydney University). 
3.2.3 Extraction of plant material 
Plant materials was prepared in a way consistent with the preparation methods described by 
the YMR (personal communication), within 48 hours of collection. To prepare the plant 
material for extraction, the vascular spines of L. glutinosa were first removed to replicate the 
YMR bush products methods; other plant material was left intact. 20 to 40 grams of the fresh 
plant material was homogenised by grinding (Model BBL300, Breville); remaining material 
was dried in a drying oven at 60°C for 4 days, homogenised by grinding and stored in PPE jars 
at ambient temperatures for the duration of this project.  
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Unless specified otherwise, fresh plant material was extracted by decoction or as an aq. 
ethanol extracts. These extracts were used throughout this research. Extracts were stored at 
4°C for the duration of the project.  
 Aqueous extracts 
Plant materials (10 % w/v), were boiled with deionised water for 20 min, on a hot plate (RCT 
B518, Radleys, United Kingdom). The extracts were then filtered under vacuum (Whatman® 
filter paper) to remove the plant material, and the resulting extract lyophilised (Alpha 1-4 LD 
Christ, Germany) for 7 days. The powdered crude extract was stored at 4 °C, prior to analysis. 
 Aqueous ethanol extracts 
Plant material was covered with 70% aq. ethanol at a ratio of 10% w/v fresh weight and left 
to steep for 24 hours at room temperature. Extracts were filtered under vacuum (Whatman® 
filter paper) and solvents evaporated in the fume cupboard for 4 days. The dried extracts 
were then lyophilised to remove residual water for a further 7 days. The powdered extract 
was stored at 4 °C, prior to analysis. 
3.2.4 Antimicrobial screening 
 Microorganisms 
Microbial screening was approved by the Western Sydney University Biosafety and Radiation 
Safety Committee (BRSC No. B10630). The bacterial and yeast strains (Table 2) were kindly 
donated by the Biomedical Sciences Department at Western Sydney University.  All 
organisms were American Type Culture Collection (ATCC®) strains and stored on MicroBank™ 
beads at -80°C until analysis. At the time of analysis, microbial colonies were isolated on solid 
growth stored at 4 °C, selected and used to prepare working liquid cultures. Details are 
provided in Table 3.  
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Table 3 Microorganisms and their optimal growth conditions 
Microorganism StrainA 
Optimal growth conditions  Growth mediaB 
Temp. Oxygen 
Incubation 
Time 
 
Solid Liquid 
Pseudomonas aeruginosa 13388 37 °C Aerobic 24 hrs  MHA MHB 
Candida albicans 10231 30 °C Aerobic 48 hrs  PDA SAB 
(ᴬ)American Type Culture Collection strain designation; ATCC®. (B) All growth media was prepared as per 
manufacturer’s instructions. MHA BBL™ Mueller Hinton agar (Becton, Dickenson & Company, USA); MHB 
BBL™ Mueller Hinton broth (Becton, Dickenson & Company, USA); PDA Potato dextrose agar (Oxoid, 
England) SAB Sabouraud dextrose broth (Oxoid, England) 
 Preparation of bacterial cultures 
Inoculated working liquid cultures of the selected microorganism were corrected 
spectrophotometrically (Fluostar Optima, BMG Labtech, Germany) to an absorbance of OD 
0.08 at 600 nm against a liquid media blank. The corrected inoculant was further diluted 
1:100 in sterile liquid media and used as the test microbe culture.   
 Samples and controls 
A known amount of dried extract was dissolved in 70% ethanol to a concentration of 
10 mg/mL. Purchased antibiotics- gentamicin (Sigma-Aldrich, USA) and fungazone 
(Amphotericin B) (Sigma, USA), were prepared in 70 % ethanol and included as positive 
controls for selected microorganisms (Table 4). Seventy % ethanol was also included as a 
blank.  
Table 4 Microorganisms and corresponding positive controls 
Microorganisms Positive control* 
P. aeruginosa (ATCC 13388) Gentamicin (25 µg/mL) 
C. albicans (ATCC 10231) Fungazone (amphotericin B) (2.5 µg/mL) 
* Prepared concentration of positive control in 70% ethanol 
 Microdilution assay 
Forty microliters of prepared sample were added (in triplicate) to the flat bottomed 96-well 
plate (Corning, USA), and serially diluted for a final concentration range in wells of 0.04-1.00 
mg/mL. Likewise, 40 µL of the positive control, blank (70% ethanol in liquid media), growth 
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control (no extract, antibiotic or solvent) and sterility control (no microorganism) were also 
included. The external lanes were filled with water to reduce edge effects. 
The plates were allowed to incubate under their optimal growth conditions, after which time 
the growth of the microorganism was inspected in two ways- turbidity (§ 3.2.4.4.1) and 
colourimetric (§ 3.2.4.4.2) analyses. Additionally, the bactericidal and bacteriostatic activity 
(§ 3.2.4.4.3) was also assessed. 
3.2.4.4.1 Inhibitory concentration (IC) by turbidity  
MIC was assessed by turbidity of each well, inoculated with microbial cells treated with 
extract, positive, solvent or negative controls. Absorbance of each well was taken 
spectrophotometrically (Fluostar optima, BMG Labtech, Germany) at 595 nm prior to and 
after incubation, with absorbance read using Fluostar Optima (V.1.32).  To determine if the 
extracts possessed any antimicrobial activity, differences in growth were used to determine % 
inhibition of growth control cells. This was done using Equation 1. 
Equation 1:  % 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =  [1 − (
(𝑇f−𝑇i)−𝐶S
𝐶G
)] × 100 
Where: 
Ti Absorbance of well before incubation at 600nm 
Tf Absorbance of well after incubation at 600nm 
CS  Average absorbance of sterility control wells at 600nm 
CG  Average absorbance of growth control wells at 600nm 
The average concentration inhibiting the growth (IC) of microbes was determined from three 
biologically independent assays, carried out in triplicate.  
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3.2.4.4.2 Minimum inhibitory concentration (MIC) by resazurin 
Twenty µL of resazurin solution (0.01% w/v) prepared in sterile deionised water was applied 
to each well. Plates were incubated for 1 hr under optimal growth conditions (Table 3). At 
the end of this time, results were observed visually, with the MIC recorded as the lowest 
concentration to show no colour change. The average minimum inhibitory concentration for 
each extract was determined from three biologically independent assays. 
3.2.4.4.2.1 Analysis of ability for extracts to change colour due to resazurin 
To ensure that extracts were not providing misleading MIC values, samples (final 
concentration 1 mg/mL in wells) were incubated for 1 hr in MHB/SAB media and resazurin 
(0.01 % w/v) under the same experimental conditions.  
3.2.4.4.3 Bactericidal/static activity 
Six µL of treated microbes were spotted onto appropriate sterile solid growth media and 
incubated under optimal growth conditions. Following incubation, samples were inspected 
for growth, and assessed for bactericidal inhibition by recording the concentration at which 
no new growth was observed. 
3.2.5 Anti-inflammatory screening 
 Maintenance of RAW264.7 cells 
RAW264.7 cells were provided by the Pharmacology Laboratory of NICM and grown in 
complete Dulbecco's Modified Eagle Medium (DMEM; Sigma, USA) media supplemented 
with 5% Fetal Bovine Serum (FBS, Sigma, USA), 2 mM l-GlutaMax (Sigma, USA), 100 U/mL 
penicillin, 100 µg/mL streptomycin (PenStrep, Sigma, USA). Cells were grown in T75 cell flasks, 
incubated horizontally in a 5% CO2 humidified environment at 37°C and to maintain cell 
viability and confluency, passaged every 3-4 days.  
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To passage cells, incubated flasks were initially checked for contamination and confluency 
under the microscope (AE20 Motic, USA). DMEM media was then aspirated from cells and 
washed with sterile extended name PBS (Sigma, USA) solution. Five mL of sterile 
supplemented DMEM was added and adherent cells scraped from the surface using a rubber 
cell scrapper. One mL of cells were transferred to sterile T75 flasks, diluted in nine mL of fresh 
supplemented DMEM media and returned to incubation.  
 Determination of NO production 
3.2.5.2.1 Seeding RAW264.7 cells 
To seed cells for analysis, a known concentration of harvested cells (determined by Vi-Cell 
XR, Beckman Coulter, Germany) were diluted to 8 × 105 cells/mL in sterile supplemented 
DMEM. One hundred µL (1 × 105 cells/mL) were transferred to wells of a 96-well plate 
(Corning, USA) and incubated for 48 hours. One hundred µL of water was added to external 
lanes to reduce edge effect. 
3.2.5.2.2 Preparation of samples, controls and stimulant LPS 
A known amount of plant extract, dissolved in 50% DMSO was serially diluted (1:2) in sterile 
DMEM media to obtain a concentration range of (0.03-1.00 mg/mL). Diluted 1400W 
dihydrochloride (Sigma, USA) was used as a positive control, and 50% DMSO as a negative 
control. Lipopolysaccharide (LPS; Sigma, USA) was prepared in sterile PBS to a concentration 
2 μg/mL and stored at -20°C until required. 
3.2.5.2.3 Treatment and stimulation of seeded cells 
Initially, seeded cells were refreshed with sterile supplemented DMEM media. Cells were 
treated with 20 µL of sample, positive and negative controls and incubated for 2 hours. After 
this time, 10 µL of LPS was added to cells to induce an inflammatory response from the 
RAW264.7 cells and returned for incubation for a further 24 hours.  
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3.2.5.2.4 Griess assay for determination of nitric oxide production 
Briefly, the nitric oxide concentration in the form of nitrite was determined from the medium 
of the treated cells by transferring 100 µL of the supernatant to a sterile 96-well plate. One 
hundred microliters of Greiss reagent, prepared daily as required, was added to the wells and 
the plate allowed to stand at room temperature, for 10 min. The plates were then 
spectrophotometrically measured at 540 nm on a plate reader (Fluostar optima BMG Labtech, 
Germany) to detect the violet colour, indicative of the presence of nitrite bound to the Greiss 
reagent.  
To determine the anti-inflammatory activity of the extracts, the NO production was 
determined as a percentage of the control cells (LPS stimulated and not). This was done for 
each sample by the Equation 2. 
Equation 2:  % 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =  (
(𝑤𝑒𝑙𝑙−𝑚𝑖𝑛)
(𝑚𝑎𝑥−𝑚𝑖𝑛)
) × 100 
Where: 
well Absorbance of well before incubation at 540 nm 
min Average absorbance of non-stimulated cells at 540 nm 
max Average absorbance of LPS-stimulated cells at 540 nm 
 
 Cytotoxicity by MTT assay 
To determine cell viability, treated RAW264.7 cells were incubated with 100 µL of 0.2 mg/mL 
of MTT solution in supplemented DMEM media for 2 hrs at 37⁰C. After incubation, 150 µL of 
DMSO was added to wells, and in the presence of MTT, viable cells formed violet formazan 
crystals. Plates were agitated on the plate shaker (Thermostar, BMG Labtech, USA) for 5 min, 
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and absorbance measured at 595 nm on a plate reader. Cell viability was determined as a 
percentage of non-viable cells (i.e. only DMSO), using Equation 3.  
Equation 3:  % 𝑖𝑛ℎ𝑖𝑏𝑖𝑡𝑖𝑜𝑛 =  (
(𝑎𝑣𝑔.  𝑚𝑎𝑥−𝑤𝑒𝑙𝑙)
(𝑎𝑣𝑔.  𝑚𝑎𝑥−𝑎𝑣𝑔.  𝑚𝑖𝑛)
) × 100 
Where: 
well  Absorbance of well before incubation at 595 nm 
avg. min Average absorbance of DMSO blank at 595 nm 
avg. max Average absorbance of non-treated cells at 595 nm 
 
 Statistical Analysis 
Data was collated in Microsoft Excel, with the calculated mean and S.E.M. used to determine 
the IC50 in GraphPad prism. An unpaired student t-test was also carried out to compare 
results from the extracts p<0.05. 
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3.3 Results & Discussion 
3.3.1 Systematic reviews 
 Search summary 
An electronic search of E. tetrodonta, M. dealbata and L. glutinosa was conducted in August 
2016 in electronic databases JSTOR, Pubmed, ScienceDirect, SciFinder and Scopus. Additional 
records were identified through published books and online databases. The methodology 
was identical for each plant species, with each search conducted independently of the other 
species. Articles, within the inclusion criteria outlined above, are outlined in Table 5.  
Table 5 Literature search summary (based on PRISMA guidelines) 
 Number of records (n) 
 E. tetrodonta M. dealbata L. glutinosa 
Identification    
 Records identified through databases 725 281 946 
 Additional records identified 12 10 21 
 Records after duplicates removed 627 285 842 
Screening    
 Records screened 627 285 842 
 Records excluded 603 274 744 
Eligibility    
 Included records assessed for eligibility 24 11 98 
 Records excluded with reason 0 0 0 
Included    
 Records included in qualitative studies    
o abstracts 4 0 15 
o full text 20 11 83 
 Records included in quantitative studies 0 0 0 
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 Eucalyptus tetrodonta 
The electronic literature results using the key terms for Eucalyptus tetrodonta identified 725 
electronic records- JSTOR (n=207), Pubmed (n=6), ScienceDirect (n=74), SciFinder (n=33) and 
Scopus (n=405) with an additional twelve books identified through the reference lists and 
forward citations of included papers. These records were combined and duplicates removed 
(n=110), with the remaining records (n=24) included in the current review. All records were 
focussed on an Australian context, with a publication date range from 1969 to 2015, and 
included only text based records. 
3.3.1.2.1 Ethnobotanical and ethnomedicinal use 
The ethnobotanical and ethnomedicinal uses of E. tetrodonta were found only for the 
Aboriginal communities of the Northern Territory of Australia (Appendix VII). When in flower, 
E. tetrodonta is used as a calendar plant to indicate the best time to collect honey from 
sugarbags (Brock and Dunlop, 1993; Yunupingu et al., 1994). The bark is used as the canvas 
for bark paintings (Brock and Dunlop, 1993; Smith, 1991b; Smith and Wightman, 1990; 
Wightman et al., 1992) and hollowed branches used as didgeridu’s and drums (Brock and 
Dunlop, 1993; Moyle, 1981; Wightman et al., 1992; Yunupingu et al., 1994). The branches are 
also used as building materials to make canoes, shelters (Brock and Dunlop, 1993) and roofs 
including the roofing material of the first-health dedicated shelter (Ireland et al., 2015; 
Wightman et al., 1992). The timber is used for making spears, woomeras, dance sticks, 
digging and fighting sticks (Brock and Dunlop, 1993) and, more contemporarily, is also useful 
for building houses and fence-posts (Smith and Wightman, 1990). Leaves can be used as 
flavouring for buffalo meat (Smith, 1991b; Smith and Wightman, 1990), but also as a part of 
cultural smoking ceremonies.  
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The branches, gum, outer and inner bark, sapwood and leaves (including young leaves) have 
been used medicinally to treat illness and to improve general health. The most common 
medicinal use reported was for the external topical treatment of skin sores and scabies 
(Figure 6). Bark, inner bark & sapwood, gum or leaves were made as either an infusion or 
decoction to produce a reddish-purple liquid to be used as a wash, or crushed and applied 
directly to affected area as a poultice. 
Although, treatment for skin sores and scabies were the most common ethnomedicinal use, 
internal administration was the most common preparation found in literature. An infusion 
(or decoction) of the bark, inner bark, sapwood and leaves were used as a mouthwash to 
relieve mouth sores and an inflamed tongue, or drunk to relieve the common cold, chest 
cold, headaches, fevers and diarrhoea, post-birth pain, as well as to promote lactation. The 
leaves could also be chewed to relieve a sore throat and common cold. Branches could be 
Figure 6 Summary of the ethnomedicinal uses and treatment administration of E. tetrodonta 
by Australian Indigenous communities of the Northern Territory, Treatment by internal (58%) 
administration was more common than external (12%) administration; two were unspecified 
(6%). The most common ethnomedicinal use was found to be for skin sores and scabies. 
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burnt to produce smoke which when inhaled would relieve post-birth bleeding, or when 
burnt in a fireplace (can also be bark), a mother in labour would sit over at the time of labour, 
to relieve labour pains, and to also induce lactation (J. Reid as cited in Manderson, 1981).  
3.3.1.2.2 Chemistry 
The bark and leaves have previously tested positive for the Libermann/Burchard test, 
suggesting the presence of triterpenes or steroids and have been reported to possess 
saponins, tannic acid and triterpenoids (Aboriginal Communities of the Northern Territory of 
Australia et al., 1993; Lassak and McCarthy, 2011).  
Distilled leaves yielded 0.2% essential oils and have been found to possess monoterpenes 
and sesquiterpenes (Figure 7). Several studies quantifying the concentrations of these 
compounds have found the leaves to possess high concentrations of α-pinene 1 and 
Figure 7 Structures of compounds identified in E. tetrodonta.include (1) α-pinene; 
(2) 1,8-cineole; (3) α-terpineol and (4) globulol 
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1,8-cineole 2 (Barr et al., 1988). In addition, Williams (2011) and Coppen (2002) have also 
identified the presence of α-terpineol 3 and globulol 4 however neither specified the plant 
part from which the compounds were isolated. To the best of the author’s knowledge, no 
other analysis of E. tetrodonta chemistry has been reported.  
3.3.1.2.3 Pharmacology 
E. tetrodonta gum, inner bark and leaves have previously been reported as an effective 
antiseptic against skin sores (Isaacs, 1987; Locher and Currie, 2010; Smith, 1991b). Previously, 
varying concentrations of ethanol extracts of leaves and bark have been assessed against 
microbes Klebsiella pneumoniae, Salmonella typhimurium, S. aureus and Escherichia coli by 
an agar dilution method (Aboriginal Communities of the Northern Territory of Australia et 
al., 1993; Lassak and McCarthy, 2011). The ethanol extracts of the leaves were found to be 
active against K. pneumoniae, S. typhimurium and S. aureus at 500 µL, however no activity 
was reported against E. coli; the bark did not show any antibacterial activity against any of 
the microbes (Aboriginal Communities of the Northern Territory of Australia et al., 1993; 
Lassak and McCarthy, 2011). The plant extracts therefore demonstrated broad spectrum 
activity, however for undetermined reasons, E. coli showed no susceptibility.   
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 Melaleuca dealbata 
The search strategies for Melaleuca dealbata identified 281 electronic records- JSTOR 
(n=169), ScienceDirect (n=34), SciFinder (n=3) and Scopus (n=75), with no records identified 
in Pubmed (n=0). Six duplicates were removed and of the 275 electronic records remaining, 
one article was within the inclusion criteria. An additional ten included records were found 
through bibliography searches. The majority of the records were focused on M. dealbata in 
an Australian context; however, one article was affiliated with the Forestry and Forest 
Products Research Institute of Japan.  
3.3.1.3.1 Ethnobotanical and ethnomedicinal use  
Though not an extensive list, there are records of the ethnobotanical and ethnomedicinal 
uses of M. dealbata by the Aboriginal communities of the Northern Territory of Australia. 
M. dealbata bark is used as a building material (Wightman et al., 1992; Williams, 2011) or to 
make coolamons (‘Dhaniya’) for carrying food and other items (Burarrwanga et al., 2013). 
The bark is also used as covering for bush ovens, in which food like fish are wrapped in 
M. dealbata to cook for flavouring (Wightman et al., 1992; Yunupingu et al., 1994). 
M. dealbata is also used as a water resource; when grown in mangrove areas, the 
M. dealbata tree develops large root systems that stabilise the river bank. Additionally, the 
swellings on the trunks of M. dealbata can be utilised as a source of drinking water 
(Yunupingu et al., 1994).  
Medicinally leaves of M. dealbata are crushed in the hands or prepared as a decoction in 
water to treat the common cold or chest cold (Table 6). A decoction of crushed leaves can 
also be used an external wash for the treatment of skin sores.  
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Table 6 Ethnomedicinal uses of M. dealbata 
Plant part Administration Treatment for Preparation Reference 
Leaves Inhaled Chest cold Crushed in hands; 
Decoction in water to 
produce vapour 
(Smith, 1991a; Smith and 
Wightman, 1990; 
Yunupingu et al., 1994) 
Drink Common cold Decoction YMR Rangers, unpubl. 
Wash Skin sores Decoction of crushed 
leaves 
(Smith, 1991a; Smith and 
Wightman, 1990; Wightman 
et al., 1992) 
 
Interestingly, the ethnomedicinal field notes of Smith (1991a) identified the local vernacular 
“Nambarra” of M. dealbata, the same as another Melaleuca - M. cajuputi. For future 
investigations it would be worthwhile to investigate the literature of M. cajuputi for the 
ethnomedicinal uses by Aboriginal and Torres Strait Islander communities, as well as 
phytochemistry and pharmacology. Indigenous classification systems are not aligned with 
the ‘Western’ processes for differentiation. It is therefore possible that for some 
communities, M. dealbata and M. cajuputi are interchangeable- that is they consider both to 
be Nambarra.  
3.3.1.3.2 Chemistry 
The essential oils of M. dealbata leaves have been studied and the yields from the plant 
material have been found to range from 0.06% (Yatagai et al., 1998) to 0.1-0.2% (Brophy et 
al., 2013; Brophy and Doran, 1996).  One study reported a yield of 1.5% essential oil with the 
major compound identified as leptospermone, however the method by which this yield was 
obtained is not discussed, nor the geographic location or origin of the plant material (Lassak 
and Southwell, 1977 cited in Brophy, 1999).   
  
66 
M. dealbata oil has been reported to contain secondary metabolites classified as 
monoterpenes, sesquiterpenes, benzaldehydes, phenylpropanoids, esters and steroids 
(Appendix VIII). The most frequently reported constituents include sesquiterpenes 
β-caryophyllene 6, caryophyllene oxide 10, globulol 4 (§ 3.3.1.4) and spathulenol 7  
with monoterpenes α-pinene 1 (§ 3.3.1.4), β-pinene 5, terpinen-4-ol 8 and limonene 9 
(Brophy et al., 2013; Brophy and Doran, 1996; Yatagai et al., 1998).  
Figure 8 Structures of some compounds identified in M. dealbata essential oils. Compounds 
include (5) β-pinene; (6) β-caryophyllene; (7) spathulenol; (8) terpinene-4-ol; (9) limonene; 
and (10) caryophyllene oxide.  
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Though Brophy and Doran (1996) identified 1,8-cineole 2 (§ 3.3.1.4), it was not present in the 
essential oil of M. dealbata leaves grown in Thailand (Yatagai et al., 1998). Differences in 
essential oil composition due to varying geographical location was also shown by Brophy and 
Doran (1996) who analysed the oil of M. dealbata leaves obtained from a plant grown in the 
northeast location contained more monoterpenes than the plant grown in southeast 
Queensland, which contained more sesquiterpenes (Brophy and Doran, 1996).  
3.3.1.3.3 Pharmacology 
From the literature search results, no records were found to report the pharmacology of 
M. dealbata. However, an additional search did uncover a study of six Melaleuca oils 
(including M. dealbata) tested for miticidal activity (Yatagai et al., 1998). M. dealbata 
essential oils were extracted from fresh leaves by boiling plant material in distilled water for 
14 hours, with extracts tested for effect against Dermatophagoides pteronyssinus mites at 
two doses- 0.13 and 1.28 µg cm2. Results showed that the essential oil of M. dealbata had a 
50% lethal effect at 0.13 µg cm2 three days after treatment, thus exhibiting a mild miticidal 
activity (Yatagai et al., 1998). 
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 Litsea glutinosa 
Electronic searching of the databases resulted in 946 records for L. glutinosa; JSTOR (n=119), 
Pubmed (n=246), ScienceDirect (n=106), SciFinder (n=167) and Scopus (n=308). An additional 
21 texts (10 books and 11 articles) were identified through reference lists of included papers 
and forward citations. Records were combined and duplicates removed (n=125), screened 
according to the inclusion and exclusion criteria to give 98 records to be assessed for 
eligibility. All 98 records were included, of which full texts were obtained for 83 records; 15 
records were abstracts only. Records ranged from years 1927 to 2016 and included journal 
articles, books and conference papers.  
Thirty-five % of the obtained records contained information regarding the ethnobotanical 
and/or ethnomedicinal uses; 31% regarding the phytochemistry and 24% pharmacological 
studies. The remaining articles contained a combination of the foremost mentioned 
categories. In comparison to species E. tetrodonta and M. dealbata, this species returned the 
most number of records for assessment, probably attributed to the wide distribution of the 
species in Australia, Asia and Mauritius.  
3.3.1.4.1 Ethnobotanical and ethnomedicinal use 
L. glutinosa, is a type of bush medicine used in Northern Australia (Burarrwanga et al., 2013), 
as well as South East Asia. In this systematic review, the ethnobotanical and ethnomedicinal 
records were found from Bangladesh, India, Sri Lanka, China, Philippines, Australia and 
Mauritius.  
The ethnobotanical uses utilise the wood, roots and leaves of this laurel. Aboriginal 
Australians use the wood to make axe handles (Smith, 1991b; Smith and Wightman, 1990) 
and woomeras (Melzer and Plumb, 2007), and boil the roots to produce a yellow-orange dye 
(Brock and Dunlop, 1993; Melzer and Plumb, 2007). In the Philippines, the leaves are 
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macerated in water and combined with lime to produce a distinctive mortar used in building 
(Vanoverbergh, 1927), possibly due to the astringent quality of the plant.  
The ethnomedicinal uses of L. glutinosa are varied between region, preparation and plant 
part/s used (Appendix IX). The bark, bark gum, inner bark, berries, leaves (young and mature), 
stem bark, roots and seeds are used individually and in various combinations. These can be 
prepared by being chewed, ground, mashed or crushed to release vapours or juices or the 
plant material infused or boiled with water to create an infusion or decoction. These can then 
be administered for internal use as a drink to relieve gastrointestinal discomfort, abdominal 
pain and boost immune systems or as eye drops for infected eyes. Externally, the plant 
material can be used as a poultice, cataplasm or salve to treat injuries and infections to the 
skin or broken/fractured bones, or additionally, the oils and juices used as an ointment to 
treat inflamed joints and bones. In addition to being utilised as a single herb, in Bangladesh, 
India and Mauritius, records indicate that the plant material is combined with other plants 
and milk in a compound preparation (Khatun et al., 2014; Rahmatullah et al., 2014; Samoisy 
and Mahomoodally, 2015; Sharkar et al., 2013). These ethnomedicinal uses of L. glutinosa 
may be attributed to its pharmacological activity but also to its astringent, mucilaginous and 
demulcent qualities.     
3.3.1.4.2 Chemistry 
A review of the chemistry of the genus Litsea, including species L. glutinosa were undertaken 
in 2011 (Agrawal et al., 2011) and 2016 (Wang et al., 2016). A plant of ethnomedicinal 
significance for many communities in Australia, Asia and Mauritius, it has been the focus of 
several studies which have identified chemical constituents found in dried and fresh leaves, 
fruits, bark, stems, heartwood, fruit oil and leaf oil (Table Appendix XI).  
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Table 7 L. glutinosa phytochemicals 
Extract Compounds Reference 
Essential oils monoterpene, diterpene, sesquiterpene, 
fatty alcohol, fatty acid, alcohol, diyne, 
ester, ketone, phenol, polyphenol, 
phenylpropenes 
(Choudhury et al., 1996; Chowdhury et al., 
2008; Qin et al., 2012; Son et al., 2014; Zhou, 
2012) 
Water flavonoid, flavonoid glycoside, 
monosaccharides, polysaccharides 
(Das et al., 2013a; Herath et al., 1990; 
Mahmud et al., 1993; Mohan et al., 1975, 
1978) 
Ethanol alkaloid, flavonoid, flavonoid glycoside, 
Glucopyranoside, glycoside, 
megastigmane O-glucopyranosides, 
lignan, fatty alcohol, Phenol, Phenolic 
acid, plant sterol, Polyphenol, 
Polyphenol amine 
(Bhakuni et al., 1977a; Collins and CSIRO, 
1990; Haque et al., 2014; Hart et al., 1969; 
Ndi et al., 2016; Pan et al., 2010; Tewari et 
al., 1974; Wang et al., 2010; Wang et al., 
2012; Wang et al., 2008; Xu et al., 2016; 
Yang et al., 2005) 
Methanol  butenolides, monoterpenes (Agrawal et al., 2013) 
PET fatty acids (Ninh et al., 2015) 
Ethyl acetate Ester, fatty acid, plant sterol (Ninh et al., 2015) 
Hexane fatty alcohol, fatty acid ester (Ninh et al., 2015) 
Unspecified alkaloid, sesquisterpenes (Aboriginal Communities of the Northern 
Territory of Australia et al., 1993; Barr et al., 
1988; Bhakuni and Jain, 1988; Bhakuni et al., 
1977a; Bhakuni et al., 1977b; Collins and 
CSIRO, 1990; Hart et al., 1969; Lassak and 
McCarthy, 2011; Morton, 1990; Tewari et al., 
1974) 
 
In an Australian context, plant material sourced from Northern Australia has been studied to 
elucidate the chemical properties of L. glutinosa responsible for the observed 
ethnomedicinal uses. The leaves and stems of the species have been shown to possess an 
essential oil yield of 0.03% that are positive for triterpenes, steroids and saponins (Barr et al., 
1988; Collins and CSIRO, 1990). Positive reactions for Dragendorff's, Mayers and Silico-
tungstic acid tests have confirmed the presence of alkaloids in bark and combined leaf and 
bark samples, whereas a negative result for alkaloids were found in the leaves (Barr et al., 
1988). More recently Ndi et al. (2016) have found alkaloids in the 80% aq. ethanol extracts 
of leaves and stems obtained from north Queensland; specifically aporphine compounds 
N-methylactinodaphnine, boldine, N-methyllaurotetanine and isoboldine.  
The majority of the references identify decoctions and diffusions as the preparation method 
for ethnomedicinal use, and similarly, chemical elucidation studies have focused on plant 
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material extracted in water by steam or hydro-distillation to give the essential oils or water 
extracts, or by steeping in aq. alcohol mixtures. These methods have identified a vast range 
of compounds from various classes including alkaloids, flavonoids, monoterpenes, 
sesquiterpenes, glycosides, mono- and polysaccharides, fatty acids and lignans (Table 7; 
comprehensive list Appendix XI). 
3.3.1.4.3 Pharmacology 
A range of bioactivities have been reported for the leaves, bark and stems of Litsea glutinosa, 
namely antimicrobial, anti-inflammatory, antithrombotic, antioxidant, wound healing and 
cell proliferation studies such as anticancer and antitumor activities. Additionally, the effects 
of Litsea glutinosa on the cardiovascular system and central nervous system have also been 
studied, including toxicity.  
 Antimicrobial activity 
Numerous studies have determined Litsea glutinosa to be an active antimicrobial agent 
against a range of gram positive and gram negative bacteria, and fungi (Table 8).  The most 
common method for analysis was the disc diffusion method, by which a disc impregnated 
with a known concentration of plant extract was placed onto inoculated solid media. Bacteria 
S. aureus, E. coli, Proteus sp. P. aeruginosa and Salmonella paratyphi were all shown to be 
inactive against petroleum ether and chloroform extracts of the leaves and bark (Pradeepa 
et al., 2011).  
 
Table 8 Antimicrobial activity of L. glutinosa extracts 
Microbe 
Plant 
part 
ExtractA 
Conc 
(mg/ml) 
MethodB Reference 
Gram positive bacteria      
Bacillus cereus  L MeOH 1.0 DD (Meera and Devi, 2009) 
B EtOH 1.0 DD (Lohitha et al., 2010a) 
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- MeOH 0.2 DD (Mandal et al., 2000) 
Bacillus pumilus  - MeOH 0.2 DD (Mandal et al., 2000) 
Bacillus subtilis  L EtOH, PET, CF 0.4-20 DD, MD (Gulzar et al., 2015; 
Pradeepa et al., 2011) 
B EtOH, PET 2.5-5.0 DD, MD (Pradeepa et al., 2011) 
- MeOH 0.2 DD (Mandal et al., 2000) 
Lactobacillus arabinosus - MeOH 0.2 DD (Haque et al., 2014; 
Lohitha et al., 2010a; 
Pradeepa et al., 2011) 
Micrococcus luteus L MeOH 1.0 DD (Mandal et al., 2000) 
Sarcina lutea L EtOH, MeOH 0.2-0.4 DD (Pradeepa et al., 2011) 
Staphylococcus aureus L EtOH, MeOH 0.4-2.5 DD, MD (Gulzar et al., 2015; 
Haque et al., 2014; 
Meera and Devi, 2009; 
Pradeepa et al., 2011) 
B EtOH, PET, CF 1.0-10.0 DD, MD (Haque et al., 2014; 
Lohitha et al., 2010a; 
Pradeepa et al., 2011) 
- MeOH 0.2 DD (Mandal et al., 2000) 
Streptococcus pneumoniae - MeOH 0.2 DD (Mandal et al., 2000) 
Gram negative bacteria      
Escherichia coli  L EtOH, MeOH 0.4-1.0 DD, MD (Gulzar et al., 2015; 
Haque et al., 2014; 
Meera and Devi, 2009; 
Pradeepa et al., 2011) 
B EtOH, PET, CF 1-20 DD, MD (Meera and Devi, 2009) 
- MeOH 0.2 DD (Hosamath, 2011) 
Klebsiella pneumoniae  L EtOH, CF 5.0 DD, MD (Gulzar et al., 2015; 
Haque et al., 2014; 
Meera and Devi, 2009; 
Pradeepa et al., 2011) 
Proteus mirabilis - MeOH 0.2 DD (Pradeepa et al., 2011) 
Proteus sp.  L EtOH, CF 5.0-20.0 MD (Mandal et al., 2000) 
B EtOH, PET, CF 0.2-20.0 MD (Meera and Devi, 2009) 
- MeOH 0.2 DD (Mandal et al., 2000) 
Pseudomonas aeruginosa L EtOH, MeOH, 
PET, CF 
0.4-20.0 DD, MD (Pradeepa et al., 2011) 
B EtOH, PET 1.0-20.0 DD, MD (Pradeepa et al., 2011) 
Salmonella  paratyphi L EtOH, CF 0.4-20.0 DD, MD (Mandal et al., 2000) 
B EtOH, CF 5.0-10.0 MD (Gulzar et al., 2015; 
Meera and Devi, 2009; 
Pradeepa et al., 2011) 
Salmonella typhi L EtOH, PET, CF 5.0-20.0 DD, MD (Lohitha et al., 2010a; 
Pradeepa et al., 2011) 
B EtOH, PET, CF 2.5-10.0 MD (Gulzar et al., 2015; 
Pradeepa et al., 2011) 
Salmonella typhimurium L MeOH 0.2-1.0 DD (Pradeepa et al., 2011) 
Shigella boydii L EtOH 0.4 DD (Mandal et al., 2000; 
Meera and Devi, 2009) 
Shigella dysenteriae L EtOH, MeOH 0.2-0.4 DD (Gulzar et al., 2015; 
Mandal et al., 2000) 
Shigella sonnei - MeOH 0.2 DD (Mandal et al., 2000) 
Vibrio cholera - MeOH 0.2 DD (Mandal et al., 2000) 
Vibrio mimicus L EtOH 0.4 DD (Gulzar et al., 2015) 
Vibrio parahaemolyticus L EtOH 0.4 DD (Gulzar et al., 2015) 
Fungi      
Aspergillus fumigatus - Water, EtOH, 
PET 
0.1  CD (Hosamath, 2011) 
Aspergillus niger  L MeOH 1.0 DD (Meera and Devi, 2009) 
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Candida albicans L MeOH 1.0 DD (Meera and Devi, 2009) 
- EtOH, PET, CF 0.1 CD (Hosamath, 2011) 
 (-) denotes unspecified data; (L) denotes leaves; (B) denotes bark; (A)extract solvent (EtOH) ethanol, (MeOH) 
Methanol, (PET) Petroleum ether, (CF) Chloroform; (B)method for antimicrobial assessment (DD) denotes disc 
diffusion; (CD) denotes well-agar diffusion method; (MD) denotes agar dilution method.  
Furthermore, although the plant part were not specified, Arora and Kaushik (2003) found the 
methanol extracts of L. glutinosa were inactive against fungi C. truncatum, F. orysporum and 
M. phaseolina. 
 Antioxidant activity 
The antioxidant activity of Litsea glutinosa leaves, stems, bark and leaves have been studied. 
The mucilage obtained from the leaves extracted with water was assayed by 2,2-diphenyl-1-
picrylhydrazyl (DPPH) assay and found to have an inhibitory concentration to reduce the 
DPPH concentration by 50% to be 490 µg/mL (Kshirsagar and Upadhyay, 2009; Palanuvej et 
al., 2009) also compared the methanol extract and sequential petroleum ether, DCM, ethyl 
acetate and methanol sub-fractions to a trolox standard and found that the methanol extract 
had a 41.53% capacity to scavenge DPPH, whereas the ethyl acetate and methanol sub-
fractions were 92.89 and 91.39% respectively (Kshirsagar and Upadhyay, 2009). Additional 
DPPH assays found the methanol extract of the bark to be comparable to ascorbic acid 
(Ghosh et al., 2016) and to have a IC50 of 30.24 µg/mL (Devi and Meera, 2010). Other tests to 
determine the antioxidant capacity of L. glutinosa, such as nitric oxide scavenging assay and 
hydrogen peroxide scavenging activity found activity to be dose dependent (Devi and Meera, 
2010; Ghosh et al., 2016; Rumzhum et al., 2013).  
 In vitro studies 
Results from Collins and CSIRO (1990) reported cytotoxic activity of Litsea glutinosa extracts 
against Sarcoma 180 cells, but not against Lymphoid leukemia L1210, or P388 Lymphocytic 
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leukemia cells. It is however unclear the extraction solvent of the active and inactive fractions 
(Collins and CSIRO, 1990). A single compound, leurotetanine, was isolated and identified 
from Litsea glutinosa and assessed for its anti-tumor activity against Sarcoma 180 cells to a 
dose of 60 mg/kg however it was found to be inactive and not a contributor to the anti-tumor 
activity seen for the extract (Collins and CSIRO, 1990). Similarly, a study was conducted more 
recently by (Ndi et al., 2016), who isolated four alkaloids from L. glutinosa leaves responsible 
for anti-proliferative properties against various immortalised cell lines. Crude ethanol 
extracts partitioned to give n-hexane, DCM and 70% aq. methanol fractions were first all 
tested against Jurkat E6-1 (clone), MCF-7 and SKMEL28 cells, with the DCM sub-fraction 
tested against an additional three cell lines- HT29, A549 and nHEK cells. The DCM sub-fraction 
was found to be the most active and had an IC50 of 25.8 µg/mL against nHEK cells; n-hexane 
and 70% aq. sub-fractions had no observed effect against any of the tested cells lines.  
Nualkaew et al. (2012) tested the effectiveness of the water extract of L. glutinosa leaves for 
wound healing and promotion of cell proliferation. In vitro cell proliferation studies against 
human dermal fibroblasts, and immortalised human keratinocyte cell line (HaCaT), found 
that the crude extracts at a concentration of 100 µg/mL were able to increase HaCaT 
proliferation by 150%, but had no significant effect against dermal fibroblasts. After 
fractionation to yield a high molecular raw polysaccharides and low molecular weight 
fraction, it was found that the latter at a concentration of 50 µg/mL, was able to increase 
HaCaT proliferation by 160%. This preliminary study suggests a possible pharmacological 
reason for the traditional use of L. glutinosa leaves for skin wounds. In addition, two other 
studies investigated the antithrombolytic activity of the methanol extracts of L. glutinosa 
(plant parts unspecified) and both using human blood samples, found it to have moderate to 
mild activity at 46.78 % (Bhowmick et al., 2014; Mahmud et al., 2015). 
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The mucilage (water extract) of this laurel has also been studied to determine the 
pharmacological properties for its traditional use for diabetes, its ability to entrap glucose via 
dialysis tubing technique, and inhibit alpha-glucosidase (Palanuvej et al., 2009). The positive 
results suggested that the dried mucilage powder in a 2% mucilage suspension was able to 
entrap glucose, and thus release less glucose in solution. In addition, L. glutinosa mucilage 
could inhibit alpha-glucosidase 41% at 0.5% concentration, in comparison to the control 1-
deoxy-norjirimycin, which inhibited alpha -glucosidase by 47.6%.  
 In vivo studies 
The toxicity of L. glutinosa was assessed in brine shrimp (Khatun et al., 2014), albino mice 
(Pradeepa et al., 2013) and rats (Devi and Meera, 2010; Ghosh et al., 2016; Lohitha et al., 
2009). Petroleum ether, chloroform, acetone, ethanol, and chloroform:water (1:1) extracts 
of the bark and leaves given to Wistar albino rats and Swiss albino mice 3200 mg/kg, showed 
no mortality (Lohitha et al., 2009; Pradeepa et al., 2013). Ethanol bark extract given to starved 
Wistar rats up to 2000 mg/kg also did not cause mortality, however (Devi and Meera, 2010) 
did report effects to the central nervous system, cardiovascular system and respiratory tract 
at this dose. In contrast, the lethal concentration to destroy 50% of the brine shrimp 
population was 114.71 µg/ml for ethanol (Khatun et al., 2014) and 530 µg/ml for 75% aq. 
ethanol (Gulzar et al., 2015) leave extracts. Additionally, an anthelmintic assay found that the 
ethanol extract of the bark to caused paralysis and death against Pheretima posthuma at 40 
mg/ml (Lohitha et al., 2010b). 
The effects of leaf and bark alkaloids to the cardiovascular system and central nervous system 
were studied in anaesthetised cats and mice, respectively (Collins and CSIRO, 1990). To the 
cardiovascular system, it was observed that at 1-2 mg/kg there was a rise in blood pressure 
and violent twitching, 5-10 mg/kg pressor effect with marked hypertension and a non-
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response to adrenaline, noradrenaline and DMPP, and 10 mg/kg with sustained hypertension, 
further inhibited and reversed adrenaline responses. Hypotensive effects were also observed 
in anaesthetised dogs given 25 mg/kg L. glutinosa essential oils which caused a prolonged 
reduction in blood pressure over a period of 4-5 hours (Kar et al., 1970). (Ghosh et al., 2016) 
demonstrated that the bark methanol extract had hepatoprotective activity. Hepatic damage 
was induced in rats by administering paracetamol and tetrachloromethane, with those 
animals treated with the plant extract reducing AST, ALT, SALP and serum albumin in a dose 
dependent manner (Ghosh et al., 2016).  
To the central nervous system of mice, 100-500 mg/kg caused a decrease in motor activity 
and at 2000 mg/kg resulted in asphyxia convulsions and death. The essential oils in rats had 
an analgesic and sedative effect (Menon et al., 1970). Devi and Meera (2010) and Bhowmick 
et al. (2014) both demonstrated the methanol extracts could inhibit oedema in albino rats 
and mice at a dose of 250-500 mg/kg. At a dose of 500 mg/kg of the methanol extract, 
analgesic properties were observed that could inhibit pain from acetic-acid induced writhing 
and hot plate test (Bhowmick et al., 2014). At a dose of 100-300 mg/kg, the ethanol extract 
of the leaves had antinociceptive properties and at 250 mg/kg the methanol extract reduced 
pain by 69.5% in acetic acid induced swiss albino mice (Pradeepa et al., 2013; Rumzhum et 
al., 2013). Collins and CSIRO (1990) further showed that the leaf and bark alkaloids at doses 
50-100 mg/kg and 100-200 mg/kg, respectively, had some analgesic activity in male rats.  
Male Wistar albino rats were also studied to determine if L. glutinosa bark could improve 
male reproduction and sexual health. Lohitha et al. (2009) extracted the bark in various 
solvents - petroleum ether, chloroform, acetone, ethanol and chloroform: water (1:1), 
improved the sperm density and sperm motility of the rats. Lohitha et al. (2009) also 
observed that the ethanol bark extract possessed aphrodisiac properties.  
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Furthermore, in addition to the in vitro  methods used to assess wound healing, Devi and 
Meera (2010) studied an incision and excision wound model in anaesthetised rats. Results 
demonstrated that 2-4% w/w of the ethanolic extract had significant potential to heal 
wounds (Devi and Meera, 2010). Furthermore, Rangrez et al. (2011) investigated the 
osteoprotective effect in virgin female Wistar rats using an ovariectomised rat model, and 
found the water extract (plant part not specified) at 200 mg/kg body weight had ameliorated 
changes induced by the ovariectomy, and thus concluding L glutinosa has an osteoprotective 
effect (Rangrez et al., 2011). This supports the traditional uses not only its physical mucilages 
properties, but also a tonic for broken bones and fractures (§3.3.1.4.1). 
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3.3.2 Antibacterial activity 
The aq. and aq. ethanol extracts of the leaves of E. tetrodonta, M. dealbata and L. glutinosa 
were assessed for their ability to inhibit the growth of gram-negative bacterium P. aeruginosa 
and fungus C. albicans. The susceptibility of the microbes to the aq. and aq. ethanol extracts 
(concentration range 0.03-1 mg/ml) was measured by microdilution turbidity IC and 
resazurin MIC assays. Additionally, extracts were assessed for their bactericidal or 
bacteriostatic activity. Table 9 reports IC80 of both microbes, as well as the IC60 for 
P. aeruginosa, their MIC values and observed bactericidal or -static activity, determined from 
three biological replicates.  
Table 9 Antimicrobial activity of YMR plant crude extracts against P. aeruginosa and C. albicans 
Plant Extract 
Pseudomonas aeruginosa 
ATCC® 13388 
 Candida albicans 
ATCC ® 10231 
IC60 A IC80 B MIC C 
 IC80 B MIC C 
E. tetrodonta Aq. 125 
(125-250) 
1000 125 
(125-250) 
 250 
(250-500) 
250 
Aq. EtOH 250 1000 ND  250 250 
M. dealbata Aq. 250 1000 500  ND 1000 
(500-1000) 
Aq. EtOH 125 
(125-250) 
1000 
(1000-ND) 
125 
(125-250) 
 1000 1000 
L. glutinosa Aq. 1000 1000 ND  ND ND 
Aq. EtOH 500 1000 
(1000-ND) 
500  ND ND 
Positive control D 0.31 0.31 0.31*  0.13 
(0.06-0.13) 
0.13* 
(0.06-0.13) 
(ND) denotes no activity detected. Results were determined from three biological replicates, each carried out 
in triplicate, with results averaged for all experiments [x µg/mL (range)]. The concentrations represented are 
the aqueous (Aq.) and aqueous ethanol (Aq. EtOH) plant crude extracts inhibitory concentration that inhibits 
the growth of cells by (A) 60% and (B) 80%, as determined by a difference in turbidity in comparison to 
untreated cells. (C) The minimum inhibitory concentration (MIC) was determined by the addition of resazurin 
and observable colour change due to the presence of viable cells. (D) Positive controls were gentamicin for P. 
aeruginosa and fungazone (amphotericin B) for C. albicans. (*) denotes bactericidal activity. 
 
Antibacterial activity towards P. aeruginosa cells was not observed for any of the extracts at 
IC80 threshold. At IC60 however, inhibitory activity was present and confirmed by resazurin 
MIC results.  Pseudomonas was inhibited by both water (125 µg/mL) and ethanol extracts 
(250 µg/mL) of E. tetrodonta; the latter was only confirmed by turbidity assessment as no 
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observable colour change was detected by the addition of resazurin. In addition, these 
activities were determined to be bacteriostatic, as growth was observed for P. aeruginosa 
treated cells after incubation on solid media. Likewise, C. albicans was also susceptible to 
both E. tetrodonta extracts at concentration 250 µg/mL, and similarly, the extracts exerted 
only a fungistatic effect on its growth. Extracts of L. glutinosa had no antifungal activity 
against C. albicans, and only moderate to low activity against Pseudomonas with most of the 
activity possessed by the ethanol extract (500 µg/mL). 
M. dealbata was more effective at inhibiting P. aeruginosa than C. albicans. The MIC results 
confirmed that the growth of P. aeruginosa was negatively affected by both M. dealbata 
ethanol (125 µg/mL) and water (250 µg/mL) extracts. Additionally, the ethanol extract of M. 
dealbata inhibited the growth of C. albicans (1000 µg/mL). Although M. dealbata water 
extract showed resazurin MIC no IC80 was recorded, due possibly to the sedimentary growing 
behaviour of C. albicans affecting the turbidity reading. Conversely, the resazurin MIC could 
be erroneous due to a colour change resulting from the reduction of resazurin to resorufin 
by the plant sample and not as a result of viable cell metabolism.  
Antimicrobial activity has previously been conducted on the leaves and bark extracts of 
E. tetrodonta and it was found to have inhibitory activity against gram negative Klebsiella 
pneumoniae, Salmonella typhimurium but no activity against Escherichia coli (Aboriginal 
Communities of the Northern Territory of Australia et al., 1993). Additionally, the water leaf 
extract was active against S. aureus although a precise concentration was not quoted. This 
inhibition was also repeated in our laboratory in previous experiments against S. aureus, 
which was inhibited at a concentration of 500 mg/mL. Disc diffusion and agar diffusion assays 
have confirmed previously in literature that various extracts of L. glutinosa leaves have 
inhibitory activity against P. aeruginosa, S. aureus, S. pyogenes and C. albicans (see Table 8). 
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This is however, to the best of the author’s knowledge, the first record of the inhibitory 
activity of 70% aq. ethanol extracts of M. dealbata leaves against S. aureus and P. aeruginosa.  
The colour change due to the plant material was also assessed by replicating the 
microdilution resazurin MIC assay without the addition of microbes (Figure 9). At a 
concentration of 1 mg/mL there was an observable colour change detected at 1hr for E. 
tetrodonta and M. dealbata aq. and aq. ethanol extracts in Mueller Hinton broth (MHB)- at 
24 hrs there was a complete colour change to red. Conversly, L. glutinosa showed no change 
in the MHB, no did the solvent (70% Ethanol) or blank (MHB).  Samples added to SAB did also 
change colour, however, so too did the solvent and blank. At 48 hrs there was a greater 
difference in colour between the solvent and blank and the samples. Any observed colour 
change demonstrated that chemical compounds of the plant extracts had the potential to 
act as reductive moieties and mimic the same colour change that is seen from viable cells. 
Implications of such a result could be classed as erroneous due to the unreliability of the 
result, and disproportional estimation of cell numbers. 
Figure 9 Resazurin colour change in the presence of plant extract over time. Samples were added at to 
(A) MHB and (B) SAB at a concentration of 1 mg/mL. Colour change was observed in both liquid broths 
at the maximum time point in comparison to the (Solv) solvent and (B) blank controls. S1- E. tetrodonta 
aq.; S2- E. tetrodonta aq. ethanol; S3- M. dealbata aq.; S4- M. dealbata aq. ethanol; S5- L. glutinosa aq.; 
S6- L. glutinosa a. ethanol extracts.  
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3.3.3 Anti-inflammatory activity  
E. tetrodonta, M. dealbata and L. glutinosa aq. and aq. ethanol extracts were assessed for 
their anti-inflammatory activity by observing their ability to inhibit the production of NO by 
LPS-stimulated RAW264.7 macrophage cells by Greiss reagent and reported as the 
concentration reducing NO production by half (IC50). Additionally, RAW264.7 cells were also 
assessed for cytotoxicity by MTT to ensure that the reduction in NO production was due to 
the samples and not as a result of any cytotoxic activity possessed by the extracts.  
The aq. and aq. ethanol extracts of E. tetrodonta demonstrated greater NO inhibitory than 
M. dealbata and L. glutinosa extracts. As shown in Figure 11a all extracts possessed inhibitory 
activity in a dose dependent manner, with four extracts inhibiting NO production by 50% 
(Table 10).  
Table 10 Concentration (µg/mL) of YMR plant leaves extracts that can reduce nitric oxide production 
of stimulated RAW 254.7 cells by 50% (IC50). 
Plant Extract 
% NO Production 
IC50 (μg/mL) 95% CI (μg/mL) 
E. tetrodonta Aq. 72.35 63.52 - 82.42 
Aq. EtOH 67.59 60.4 - 75.6 
M. dealbata Aq. (126.8) (104.1 - 154.5) 
Aq. EtOH 99.41 82.78 - 119.4 
L. glutinosa Aq. (238.4) (154.2 - 368.5) 
Aq. EtOH 77.90 68.57 - 88.50 
Positive control A 1.54 1.19 - 1.98 
IC50  represents the concentration at which the (Aq.) aqueous or (Aq. EtOH) aqueous ethanol extract inhibits 
the production of nitric oxide by 50% by stimulated RAW264.7 cells. Results were determined from three 
biological replicates, conducted in triplicate, and reported as the concentration required to reduce the 
concentration of (NO) nitric oxide production by 50% with a 95% (CI) confidence interval. Results shown in 
brackets are representative only and are beyond the concentrations tested. (A)1400W dihydrochloride.  
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Due to the poor solubility in DMSO, the highest concentration of the extracts tested was 100 
µg/mL. The dose dependent curves obtained did not follow the distinctive sigmoidal shape 
expected of a dose-reponse curve, however, an IC50 value was determined for all samples 
(marked in parentheses). These values are greater than the maximum concentation tested 
(100 µg/ml) and due to the solubility of the fractions, they could not be concluded as true 
results. The most effective extracts were therefore determined as the ethanol (67.59 μg/mL; 
95% CI 60.4 -75.6 μg/mL) and water extracts 72.35 μg/mL; 95% CI 63.52 - 82.4 2 µg/mL) of 
Eucalyptus tetrodonta  and ethanol extract of L. glutinosa (77.90 μg/mL; 95% CI 68.57 - 88.50 
μg/mL). Additionally, the aq. ethanol extract of M. dealbata also possessed NO inhibitory 
activity at 99.41 µg/mL (95% CI 82.78 -119.4 μg/mL). These extracts were not cytotoxic 
against RAW264.7 macrophage cells for the concentrations
Figure 10 Treatment of LPS-stimulated RAW 264.7 macrophage cells with (aq.) aqueous and (aq. 
EtOH) aqueous ethanol YMR crude plant extracts on (A) nitric oxide production and (B) cell 
cytotoxicity determined by the addition of MTT.   
  
83 
  
tested (3.125 - 100 μg/mL) (Figure 11b).  
Additionally, to determine if there was a significant statistical difference between aq. and aq. 
ethanol extracts at reducing NO production, each plant extract was compared to its 
counterpart by unpaired, two-tailed t-test (p<0.05) at the highest concentration tested 
(100 µg/mL). LPS-stimulated cells (100.0 ± 1.043 %, n=18) possessed the maximum threshold 
of NO production and unstimulated cells produced negligible amounts (0.0 ± 0.193 %, n=18) 
(Figure 11).  It was determined that the aq. (73.17± 2.39 %, n=18) and aq. ethanol (40.38 ± 
1.529 %, n=18) extracts of L. glutinosa affected NO production that was statistically different 
(p<0.0001). Both aq. and aq. ethanol extracts of E. tetrodonta and M. dealbata similar activity 
at the highest concentration tested that were not statistical significant for either plant. This 
data in addition to the overlapping IC50 95% CI values introduces an uncertainty that any 
difference will be observed with additional replicates for these samples. This suggests that 
both E. tetrodonta and M. dealbata possess similar inhibitory activity of NO production in 
Figure 11 Production of nitric oxide by stimulated RAW 264.7 macrophage cells treated with 
100 µg/mL (aq.) aqueous and (aq. EtOH) aqueous ethanol crude YMR plant leaf extracts. Data 
represents the mean ± S.E.M.(µg/mL) production of nitric oxide compared to DMSO treated 
control stimulated (+LPS) and non-stimulated (-LPS) cells. There was a statistically significant 
difference between the aq. and aq. ethanol extracts of L. glutinosa (****, p<0.0001). 
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RAW264.7 cells for both aq. and aq. ethanol extracts. Anti-inflammatory activity for 
E. tetrodonta and M. dealbata aq. and aq. ethanol extracts have not previously been 
reported. L. glutinosa methanol extracts have however been shown to reduce oedema in 
albino rats and mice at a dose of 250-500 mg/kg. 
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3.4 Conclusion 
In the present study, qualitative and quantitative methods confirmed that E. tetrodonta, 
M. dealbata and L. glutinosa possessed medicinal value through published literature and/or 
through antimicrobial and anti-inflammatory investigation of the aq. and aq. ethanol extracts 
of each plant. Where antimicrobial or anti-inflammatory activity was reported in literature, 
the data supported the investigations through direct findings or reinforced a pharmacological 
activity (i.e. anti-inflammatory activity).  
L. glutinosa returned the most number of records, possibly due to its distribution across Asia, 
Australia and Mauritius however E. tetrodonta had the most number of ethnomedicinal 
records localised to Australia. M. dealbata had the least number of published records of the 
three species, however it was shown here for the first time to possess antimicrobial activity 
against gram negative bacterium P. aeruginosa and in the previous preliminary screening, 
inhibitory and bactericidal activity against gram positive bacterium S. aureus. Additionally, 
the aq. ethanol leaf extract of L. glutinosa  possessed antiinflammatory activity when 
measured in vitro by the determination of % NO production from LPS-stimulated RAW264.7 
macrophage cells, which was statistically significant compared to its aq. leaf extract at the 
highest concentration tested.  
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Chapter 4 Optimisation for therapeutic 
effect 
___________________________________________________________________________ 
This chapter presents the preliminary fractionation of E. tetrodonta and antimicrobial 
screening against microorganisms S. aureus, S. pyogenes, P. aeruginosa and C. albicans. 
Additionally, E. tetrodonta was also assessed for variances in chemistry by fingerprint UPLC 
analysis when extracted in varying ethanol/water and isopropanol/water combinations. All 
three plants- E. tetrodonta, M. dealbata and L. glutinosa were also assessed under forced 
degradation studies.  
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4.1 Introduction 
Plants are a valuable source of medicinal compounds, and this is evident through the use of 
medicinal plants by civilisations through history. Preparations such as infusions and 
decoctions are common amongst ethnomedicinal extractions (§3.3.1.2.1, §3.3.1.3.1 and 
§3.3.1.4.1), however these can be inappropriate to obtain the yields of medicinal extracts 
required for commercial quantities.  
Currently, the YMR bush products are prepared on a small scale, with limitations on the 
equipment available for use. The current process for production of the bush products 
involves the addition of fresh plant materials to the product bases. The exception to this is 
the preparation of the macadamia oil based product. In this process, fresh plant material is 
added to commercially purchased macadamia oil and heated for 2 hours. After heating, the 
oil is strained and added to the product bases. Macadamia oil is used here as carrier oil, 
however preliminary analysis of infused E. tetrodonta-, M. dealbata- and L. glutinosa-
macadamia oil showed poor extraction of the plant material in comparison to aq. and aq. 
ethanol extracts prepared by steeping. Contributing factors could be the temperature (70 °C) 
and duration for extraction, but also the amount of plant material used for the extraction.  
Therefore other methods are required to extract the medicinally important compounds from 
E. tetrodonta, M. dealbata and L. glutinosa.  
Commercial techniques such as microwave-assisted, ultrasound-assisted, pressurized liquid 
and supercritical fluid extractions are common for large-scale production (Danlami et al., 
2014) however for remote communities, large-scale techniques would be unsuitable due to 
the lack of provisions and resources available.  In addition, any methods proposed should 
ideally be reproducible in remote communities with minimal need for sophisticated 
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equipment, especially if for YMR members and their bush products, manufacturing were to 
move to other communities in addition to Yirrkala. 
E. tetrodonta is a known traditional medicinal plant for the Aboriginal communities of the NT, 
Australia, with many of the preparations of this plant used for the treatment of skin infections 
(§3.3.1.2.1. The YMR use E. tetrodonta in the preparation of their bush products and with 
their desire for their products to be used by the wider community, especially the sick 
(Chapter 2), it was selected for this first part of this chapter to determine the optimal 
conditions for its extraction. The aq. ethanol crude extract of E. tetrodonta was assessed 
through activity-guided fractionation for the chemistry responsible for the observed 
antimicrobial activity in Chapter 3 (§3.3.2) and preliminary investigations. Further 
comparison studies were conducted to observe the effect of varying solvent compositions to 
the plant chemistry E. tetrodonta to infer the effect of these to the antimicrobial activity of 
the plant extract. In addition, E. tetrodonta, M. dealbata and L. glutinosa were exposed to 
accelerated conditions in forced degradation studies to assess the effects of light, heat, acidic 
and alkaline conditions could have on their product quality.     
4.1.1 Bio-guided fractionation 
Plants possess a plethora of phytochemicals, and bio-guided fractionation provides one way 
in which a plant can be assessed for its biological relevancy. Bio-guided fractionation aims to 
separate the plant extract into its most biologically important components, through a process 
of isolation using separation techniques such as liquid, column or thin layer chromatography, 
combined with assays such as antimicrobial or antiproliferation assays to determine their 
bioactive constituents (Weller, 2012) and thus assess the medicinal and therapeutic value of 
the plant.  
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Though the use of bio-guided fractionation is popular for the identification of novel drug 
leads (Fabricant and Farnsworth, 2001), it is also used for the identification of medicinally 
valuable traditional plants. Previously, (Ndi et al., 2016) reported the activity-guided 
fractionation of L. glutinosa to elucidate the chemistry responsible for the anti-cancer 
properties of the plant reported by the Kuuku I'yu Aboriginal community of the Cape York 
Peninsula, Australia. As reported in § 3.3.1.4.3, this study isolated four aporphine alkaloids 
and demonstrated their varying in vitro antiproliferation and cytotoxicity activity as well as 
in silico modelling against topoisomerase II (TopoII) enzyme (Ndi et al., 2016). Overall this 
study suggested one of the four aporphine compounds isolated, boldine, could contribute to 
the possible therapeutic effect known by the Kuuku I'yu people.  
Similarly, the YMR members are interested in both E. tetrodonta and M. dealbata as a 
potential therapeutic product (Chapter 2). Through a method of separation by column 
chromatography utilising a silica stationary phase and various compositions of organic 
solvents combined with analysis by antimicrobial microdilution assay, this chapter aims to 
test separated E. tetrodonta aq. ethanol crude extract fractions against S. aureus, S. pyogenes, 
P. aeruginosa and C. albicans and determine the active fractions responsible for any observed 
antimicrobial activity. For this chapter, the aq. ethanol crude extract of E. tetrodonta was 
selected due to its observed antimicrobial activity (§ 3.3.2) and previous preliminary studies.   
4.1.2 Solvent compositional comparison 
Compositional solvent comparison was used to compare the effect of different compositions 
of ethanol and isopropanol on the chemistry of the extracts. Differing organic concentrations 
will influence the extraction of the plant materials. The optimal extraction will be a good 
compromise between polar and nonpolar compounds.  The comparison between ethanol 
and isopropanol was used to determine if isopropanol could be used a cheaper alternative 
  
90 
to pure ethanol for the extraction solvent. Pure ethanol is taxed at a higher rate and its use 
needs to be closely documented. Using isopropanol would provide a cheaper alternative for 
extraction.    
4.1.3 Forced degradation 
Forced degradation studies are used to study the stability of chemical compounds contained 
in the plant extracts. To assess potential degradants that could be formed from the plant 
material, fresh plant extracts were submitted to conditions that are likely to form degradants.  
These conditions were acidic, alkaline, heat and UV. Each condition was used to cover various 
pathways in which degradation could occur. Information gathered from forced degradations 
studies can provide knowledge about possible degradation pathways and can ultimately be 
used to elucidate possible structures of degradants and be used to select appropriate storage 
and packaging conditions.                    
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4.2 Methodology 
4.2.1 Plant material 
E. tetrodonta, M. dealbata and L. glutinosa vouchered leaves (§ 3.3.2) were analysed in this 
chapter. Activity-guided fractionation and degradation studies were conducted on fresh 
plant material. Dried E. tetrodonta leaves (§ 3.2.2) were used for solvent composition analysis.   
4.2.2 Studies of E. tetrodonta 
Determination of the active fractions of E. tetrodonta responsible for the observed 
antimicrobial activity was carried out by column chromatography. Assessment of the 
microbial inhibitory activity of the extracts was determined through microdilution assay 
methodology outlined in Chapter 3 Section 3.2.4.4, with the inclusion of additional microbes 
S. aureus and S. pyogenes.  
Additionally, varying aq. compositions of ethanol and isopropanol were used to determine 
difference in the crude extract chemistry of E. tetrodonta and potential implications for 
antimicrobial activity. 
 Antimicrobial-guided fractionation 
4.2.2.1.1 Plant extraction 
Fresh plant leaves of E. tetrodonta were extracted in 70% ethanol (1:10 w/v) by sonication 
for 1 hour, and steeping for a further 24 hours. The resulting extract was filtered through a 
sinted funnel under vacuum, and dried by rotary evapourator. The resulting crude extract 
was stored at 4 °C until analysis. 
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4.2.2.1.2 Fractionation of E. tetrodonta leaves crude 70% ethanol extract 
The fractionation scheme for E. tetrodonta crude 70% aq. ethanol extract is summarised in 
Figure 12.   
 
Initially, the crude extract (2.0 grams) was pre-absorbed onto 5g of silica gel (60Å, 35-70 µm, 
Sigma, USA) with the addition of 100% methanol (Honeywell, USA). The mixture was dried to 
a powder by rotary evapouration, with the resulting powder used for column 
chromatography. A sintered funnel (5.0 mm OD, 80 mL bed volume (BV)) was prepacked with 
35 grams of C18 silica gel and and dry packed with the sample: silica gel powder. The column 
was equilibrated with 3 BV of hexane. The sample was eluted stepwise with solvents 
increasing in polarity. In a fume cupboard, 250 mL of pre-prepared eluent solutions of hexane, 
hexane:ethyl acetate (EtOAc) (1:1), EtOAc, EtOAc:Methanol (MeOH) (1:1), MeOH and 
MeOH:Water  were used to separate the crude extract into 6 fractions. Elution was gravity 
Figure 12 Schematic of fractionation scheme by column chromatography 
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fed and vacuum finished. The resulting elutes were collected, dried by rotary evaporation 
and stored in darkness until analysis.  
4.2.2.1.3 LC-MS Analysis 
A known amount of each fraction was dissolved in 70 % ethanol for a final concentration of 
10 mg/mL. Sample solutions were prepared and placed in the temperature controlled auto-
sampler at 4°C for the duration of the analysis. 
Chemical analysis was carried out using methods described in §4.2.4. 
4.2.2.1.4 Antimicrobial activity 
Antimicrobial analysis was conducted using methods described previously (§3.2.4.4). 
Microbes tested are outlined below (Table 11). Positive controls included gentamicin for S. 
aureus (ATCC® 25923) and P. aeruginosa (ATCC® 13388), Penicillin/Streptomycin for S. 
pyogenes and Fungazone for C. albicans. 70% ethanol was used as a blank.  
Table 11 Microorganisms and their optimal growth conditions 
Microorganism StrainA 
Optimal Growth conditions  Growth mediaC 
Temperature OxygenB Incubation  Solid Liquid 
Staphylococcus aureus 25923 37 °C Aerobic 24 hrs  MHA MHB 
Streptococcus pyogenes 19615 37 °C Anaerobic 24 hrs  HBA BHI 
Pseudomonas aeruginosa 13388 37 °C Aerobic 24 hrs  MHA MHB 
Candida albicans 10231 30 °C Aerobic 48 hrs  PDA SAB 
 (ᴬ)American Type Culture Collection strain designation. (ᴮ) Anaerobic conditions were achieved by using a 
BD GasPak EZ Incubation Container (BD Diagnostics, USA) with oxygen consumed by burning a candle 
within the sealed container. (C) All growth media was prepared as per manufacturer’s instructions. MHA 
BBL™ Mueller Hinton agar (Becton, Dickenson & Company, USA); MHB BBL™ Mueller Hinton broth (Becton, 
Dickenson & Company, USA); PDA Potato dextrose agar (Oxoid, England) SAB Sabouraud dextrose broth 
(Oxoid, England); HBA Horse blood agar (Micromedia, Australia); BHI Brain Heart Infusion (Becton, 
Dickenson & Company, USA).  
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 Solvent extraction comparison – Ethanol vs IPA 
To compare the potential of alternative solvents for the extraction of E. tetrodonta as an 
alternative to ethanol, dried plant material was extracted in varying concentrations of aq. 
ethanol and aq. isopropanol. The concentrations tested were 10%, 20%, 50%, 70% and 95% 
aq. ethanol/isopropanol. 
To 1 g of dried plant material, 10 mL of the selected solvent was added. The resulting mixture 
was sonicated for 1 hour and steeped for a further 24 hours. The samples were filtered using 
a 0.45 µm PTFE filter (Phenomenex, USA) into a 2 ml autosampler vial for fingerprint analysis 
as described in § 4.2.2.1.3. 
4.2.3 Forced degradation studies of E. tetrodonta, M. dealbata and L. glutinosa 
Forced degradation studies were carried out on fresh leaves of E. tetrodonta (5% w/v), 
M. dealbata (10% w/v) and L. glutinosa (10% w/v) extracted by sonication in 70% ethanol for 
one hour. The liquid filtered extracts were subjected to four accelerated conditions to assess 
their potential degradants in comparison to a control, untreated extracts. Samples were 
prepared in 10 mL volumetric flasks.  
Of the filtered extracts, 8 mL was taken for each accelerated condition. Thermal samples 
were heated in a 70 °C water bath (Stuart, USA) and ultraviolet samples placed in a UV lamp 
box (Gemstone, USA), both for 12 hours. To determine degradants due to acidic conditions, 
samples were treated with 5M hydrochloric acid (HCl) and heated to 70 °C in a water bath 
for 1 hour. After this time, 1 mL of 5M sodium hydroxide (NaOH) was added. Similarly, 
alkaline samples were treated with 5M NaOH, heated for 1 hour in a 70 °C water bath and 
neutralized with 1mL of 5M HCl. Eight mL of control samples were made to volume with 70% 
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ethanol. Samples were filtered through 0.45 µm PTFE filter into 2 mL autosampler vials and 
analysed by LC-MS as described in § 4.2.4.  
4.2.4 Chemical analysis by LC-PDA 
LC-PDA analyses were performed on a Waters Acquity Xevo TQ triple quadruple mass 
spectrometer coupled to a binary pump, PDA detector and an autosampler (Waters, Milford, 
USA) with a 3 µL injection volume.  
Chromatographic separation was performed using a C18 column (Phenomenex kinetex 
1.7 µM, 100 A, 150 x 2.10 mm) and ACN/H20 gradient (with 0.1% Formic acid in both mobile 
phases) employing a mobile phase gradient from 10% ACN to 95% ACN over 25 min then 95% 
ACN for 5 min (Figure 13). Samples were separated by UPLC and detected by DAD (200-500 
nm). 
 
Mass spectra was also acquired in atmospheric pressure chemical ionisation (APCI) positive 
mode with a mass range of m/z 150-800 a.m.u, with capillary voltage of of 2.5 Kv; cone 
voltage 10 V; probe temperature 350-375 °C and gas flow 300 L/h. The data was analysed by 
MassLynx software (Waters, Milford, USA). 
Figure 13 Acetonitrile mobile phase gradient for LC-MS Analysis 
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4.3 Results & Discussion 
4.3.1 Studies of E. tetrodonta 
 Activity-guided fractionation 
To determine the most active antimicrobial fractions of E. tetrodonta, its crude 70% ethanol 
extract was fractionated by column chromatography to yield six fractions based on their 
affinity for hexane, EtOAc:hexane, EtOAc, EtOAc:MeOH, MeOH and MeOH:Water. From 2.0 
grams of crude extract applied to stationary phase, fraction yields were as followed [x (yield %, 
mg w/w)]; hexane (0.2 %, 4 mg w/w); hexane:EtOAc (16.7 %, 58 mg w/w); EtOAc (0.8 %, 17 
mg w/w); EtOAc:MeOH (54.4 %, 1094 mg w/w); MeOH (10.7 %, 216 mg w/w); MeOH:Water 
(14.3 %, 288 mg w/w); unrecov. (16.7 %, 335 mg w/w). Due to the low yield of the hexane 
extract, it was combined with EtOAc:hexane fraction. This was not unexpected as the original 
crude sample from which the fractions were isolated was obtained by extraction in 70% aq. 
ethanol, and therefore fewer non-polar compounds were extracted from the plant material. 
The fractions obtained were analysed by LC-DAD to observe any varying chemistry in their 
fingerprint chromatograms. The gradient method increased in organic solvent over the 
gradient time program, and as such, the fractions eluted according to their polarity - 
MeOH:water eluted within the first 15 min whereas hexane:EtOAc began to elute at 17 min 
(Figure 14). Interestingly, no major peaks were detected in the EtOAc fraction, even though 
a sufficient concentration (10 mg/mL) of sample was prepared for analysis. There was 
however unresolved peaks eluting between 20-25 minutes.  
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Figure 14 Representative fingerprint chromatograms of E. tetrodonta 70% aq. ethanol extract fractions 
obtained from column chromatography and observed at (A) 254nm and (B) 360 nm. (7-27 minutes). 
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A common feature of E. tetrodonta 70% ethanol crude extracts is a raised baseline between 
the retention times 9-13 min at wavelength 254nm (Figure 15), denoting the elution of 
unresolved peaks when run under the LC conditions.  
 
This feature was seen in the chromatograms for the MeOH:water, MeOH, and EtOAc:MeOH 
fractions but not for the hexane:EtOAc and EtOAc fractions (Figure 14) suggesting the 
compounds responsible for this characteristic are polar in nature. Additionally, the peak 
present at the retention time of 3.5 min is present in all extracts, and at the same intensity 
at other wavelengths (360 nm), suggesting it is a possible artefact of the LC system; it was 
not present in the blank (data not shown). 
To determine the most active antimicrobial components of E. tetrodonta crude 70% ethanol 
extract, the five fractions were tested against S. aureus, S. pyogenes, P. aeruginosa and 
C. albicans by 96-well microdilution turbidity and resazurin colourmetric assays. Additionally, 
the fractions were assessed for their potential bactericidal or bacteriostatic activity. Results 
obtained (reported in Table 12) showed that S. aureus, S pyogenes and P. aeruginosa were 
susceptibility to several of the fractions; however, there was no inhibitory activity against 
Figure 15 A typical fingerprint chromatogram of E. tetrodonta 70% aqueous ethanol crude 
extract observed at wavelengths (A) 254 nm and (B) 360 nm. (7-27 minutes). 
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fungi C. albicans. This is in contrast to previous observations for E. tetrodonta aq. and aq. 
ethanol extracts (§3.3.2), which inhibited the activity of C. albicans at an extract 
concentration of 250 µg/mL.  
Table 12 Antimicrobial activity (µg/mL) of E. tetrodonta 5 fractions separated by column 
chromatography. 
 S. aureus 
ATCC® 25923 
 
S. pyogenes 
ATCC® 19615 
 
P. aeruginosa 
ATCC® 13388 
 
C. albicans 
ATCC® 10231 
 IC80 B MIC  IC80 B MIC  IC60 A MIC  IC80 B MIC 
MeOH:Water 1000 1000*  ND ND  1000 
(500-1000) 
250-1000  ND ND 
MeOH 1000 1000 
(1000-ND) 
 1000 
(500-1000) 
ND  1000 
(500-1000) 
1000 
(1000-ND) 
 ND ND 
MeOH:EtOAc 500 500*  250 250  250 250 
(250-500) 
 ND ND 
EtOAc 1000 1000*  125 125  ND ND  ND ND 
Hexane:EtOAc ND ND  500 
(250-500) 
500 
(250-500) 
 ND ND  ND ND 
Positive C 0.3 
(0.3-0.6) 
0.3* 
(0.3-0.6) 
 0.1 
(0.1-0.3) 
0.1 
(0.1-0.3) 
 1.3 
(0.6-1.3) 
1.3 
(0.6-1.3) 
 0.125 0.125 
Results were determined from three biological replicates, conducted in triplicate. All concentrations are 
(µg/mL). Concentration of fraction (µg/mL) determined by turbidity measurement to inhibit (A) 60% and (B) 
80% of cells. The (MIC) minimum inhibitory concentration was determined by the addition of resazurin to wells 
and visually inspected for colour change after an incubation time of 1 hour. (*) denotes bactericidal activity. 
(ND) no inhibitory concentration was determined. (C) Positive controls were gentamicin for S. aureus and P. 
aeruginosa; penicillin/streptomycin for S. pyogenes and amphotericin B for C. albicans. (ATCC) is an acronym 
for American Type Culture Collection.  
S. aureus was susceptible to the EtOAc:MeOH (500 µg/ml), MeOH (1000 µg/ml), 
MeOH:water (1000 µg/ml) and EtOAc (1000 µg/ml) fractions; no inhibitory activity  was 
observed for the hexane:EtOAc fraction. Additionally, at these concentrations (excluding the 
MeOH fraction) treated S. aureus microbes did not grow when plated onto sterile agar, 
suggesting these fractions possessed bactericidal activity. S. pyogenes, in contrast to 
S. aureus, was inhibited greatly by the EtOAc (125 µg/ml), EtOAc:MeOH (250 µg/ml) and 
hexane:etOAc (500 µg/ml) fractions with no activity observed for the MeOH:water fraction. 
The turbidity results for the MeOH fraction suggested some inhibition at 1000 µg/ml though 
this was not supported with resazurin MIC which showed no colour change at the highest 
concentration tested. The extracts also did not show any bactericidal activity against 
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S. pyogenes, however, after incubation it was observed that the haemolysis activity of the 
S. pyogenes was affected (Figure 16).  
Treated microbes when placed onto sterile agar, formed colonies which were no longer 
β-haemolytic (i.e. able to break down red blood cells). This observation correlated with IC 
and MIC values of the extracts, suggesting that the extracts could detrimentally modify 
S. pyogenes cell behaviour. Interestingly this was also observed for the antibiotic positive 
control.  
P. aeruginosa, the only gram negative bacterium assessed, was observed to be susceptible 
against the EtOAc:MeOH (250 µg/ml) and MeOH (1000 µg/ml) fractions. Turbidity IC60 
readings suggested that the EtOAc and hexane:EtOAc fractions were also active, however no 
inhibitory activity was recorded for the resazurin MIC. In addition, results for the 
MeOH:water extracts were not consistent throughout the assays with reported MIC of 250 
to 1000 µg/ml being observed, but no IC value determined in any biological replicate. The 
microbe was susceptible to the positive control (IC60 0.63 µg/ml; MIC 1.25 µg/ml with a range 
Figure 16 Growth of S. pyogenes treated with enriched fractions of E. tetrodonta. β-haemolysis 
activity can be seen as clearing of the red blood cells on horse blood agar. Positive control and 
(EtOAc:Hexane) ethyl acetate:hexane, (EtOAc) ethyl acetate and (EtOAc:MeOH) ethyl 
acetate:methanol show a lack of clearing suggesting that these extracts prevent the microbe 
from breaking down the red blood cells. 
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of 063-1.25 µg/ml) and had no effect against the negative control (70% ethanol). These 
results therefore suggest that other interactions may be occurring that are interfering with 
the assay and causing inconsistency in results. 
Additionally, the antimicrobial activity of the fractions obtained from column 
chromatography were compared to the crude aq. and aq. ethanol extracts of E. tetrodonta. 
It was observed that each microbe- S. aureus, S. pyogenes, P. aeruginosa and C. albicans each 
had a variable response to the enrichment of the extracts. To demonstrate this, data from 
Figure 17 Antimicrobial activity of E.tetrodonta crude, aq. ethanol and fractions against 
S.aureus, S. pyogenes, P. aeruginosa and C. albicans. Determined from resazurin MIC (µg/mL). 
(>) denotes activity that was not detected within the limits of the assay (i.e. may have activity 
greater than 1 mg/mL). 
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previous antimicrobial activity was collated with the observed MIC of this study and 
compared on a bar graph (Figure 17), with the height of the bar, indirectly proportional to 
the MIC activity. S. aureus and C. albicans were inhibited more by the crude extracts then by 
the enriched fractions, S. aureus showed inhibition at EtOAc:MeOH fraction at the same 
concentration as the crude aq. and aq. ethanol fractions. From the fingerprint 
chromatograms (Figure 17) this suggests that E. tetrodonta may possess the inhibitory 
chemistry against S. aureus in the more polar extracts. 
In contrast, where once the crude aq. and crude aq. ethanol fractions had inhibitory activity 
against C. albicans; with enrichment, all activity was lost. Two suggestions are offered here 
as possible explanations for this. Firstly, with the column chromatography method, there was 
a yield of 80% recovered from the original crude aq. ethanol sample. A group of compounds 
were retained on the silica packed column, these compounds remained retained and thus 
did not elute off the column. It could be suggested that these compounds are responsible for 
the antifungal activity observed against C. albicans however this cannot be confirmed 
without first testing the material. Secondly, the antifungal activity may require a multitude 
of differing compounds which on their own, are unable to exhibit antifungal activity, but 
together, synergistically, they have inhibitory activity.  
Similarly, the crude water extract of E. tetrodonta had previously been observed to possess 
low inhibitory concentrations against P. aeruginosa for the water sample however, this 
activity was not observed with the separated fractions. The EtOAc:MeOH fraction was shown 
to have the lowest MIC and it can be inferred that compounds responsible for the 
antimicrobial activity against gram-negative bacteria P. aeruginosa is contained within the 
EtOAc:MeOH fraction. Additionally, this fraction possessed the largest yield from column 
chromatography, and peaks observed by LC-DAD contained double the intensity than the 
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same observed peaks in the MeOH:water or MeOH. For example, one peak in particular, at 
254 nm (Figure 16a) with a retention time of 14.4 min, is double the concentration than 
either of the other polar fractions. With an increase in the concentration of this compound, 
it is suggested here that the active component is within the EtOAc fraction, and the crude 
water fraction. This is however speculative, and confirmation of this would require further 
elucidation studies to confirm the identity of these compounds, and compare their 
antimicrobial activity.  
In contrast, S. pyogenes was not susceptible to either crude extract. With enrichment through 
column chromatography, fractions EtOAc:MeOH, EtOAc and Hexane:EtOAc were effective 
against this gram positive microbe. This suggests that the late eluting non-polar compound 
contained within these fractions would be candidates for further fractionation studies to 
elucidate the chemistry and/or compounds responsible for the activity.  
Analysis of this technique shows it can provide researchers with possible targets to 
determine the biologically relevant components of traditional medicinal plant. However, it is 
not informative enough to be used as evidence for the production of a medicinal product 
with claimed antimicrobial activity for the consumer market. It does demonstrate at this 
preliminary levels, that E. tetrodonta possess good antimicrobial activity when enriched, but 
loses the antifungal activity. It demonstrated, at the preliminary level, possible targets for 
further testing and indicates possible target fractions when considering alternative 
preparation method including varying compositions of extraction solvent. It demonstrates at 
this preliminary stage, possible targets for further testing are present and that particular 
fractions should be consolidated with alternative preparation methods, such as varying 
compositions of extractions solvents. 
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  Solvent Extraction comparison for E. tetrodonta 
A comparison of differing solvent compositions of ethanol/water and isopropanol/water was 
conducted to determine the effect of solvent composition of the extraction of E. tetrodonta. 
Comparison was determined by studying the fingerprint chromatography obtained through 
UPLC at wavelengths 254 nm (Figure 18) and 360 nm (Figure 19). Varying compositions from 
10 to 95% organic yielded variances in the compounds extracted, this most likely due to the 
polarity interactions between the compounds and solvents. Both ethanol and isopropanol 
mixtures showed consistently similar extraction differences. 
At wavelength 254 nm, as the isopropanol or ethanol concentration increased in the 
extraction solvent, more peaks were eluted at a later retention time, consistent with a higher 
organic mobile phase(Figure 18). For 95% isopropanol, a reduction in intensity for the 
unresolved peaks eluting between 7.5-13 min were similar for 95% ethanol. It should be 
noted, however, at 10 and 20% isopropanol, there was an unexpected higher intensity of the 
unresolved peaks in the latter, possibly due to a loss of compounds through filtration at 10% 
isopropanol.  
Greatest differences between solvent combinations on extraction were observed at 360nm, 
with a greater number of peaks eluting with a higher organic mobile phase (Figure 19). At 95% 
organic, more peaks were observed at retention times 20-25 min, indicating that more non-
polar compounds were extracted in this combination. These compounds were not present at 
10 or 20% solvent combinations for either ethanol or isopropanol. In addition, with an 
increase in ethanol concentration, it was observed that compounds between 10-15 min were 
recorded as having less intensity as the ethanol concentration increased for extraction. This 
suggested that, unlike isopropanol, an increase in ethanol composition sacrificed extraction 
of polar compounds, and favoured extraction of compounds eluting after 20 min.  
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Figure 18 Forced degradation of E. tetrodonta and corresponding chromatogram at 254nm.. 
Representative fingerprint chromatogram of E. tetrodonta dried leaves extracted with various 
compositions of (IPA) isopropanol and (Aq. EtOH) aqueous ethanol, observed at wavelength 
254 nm. (6-27 min). 
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Figure 19 Forced degradation of E. tetrodonta and corresponding chromatogram at 360nm. 
Representative fingerprint chromatogram of E. tetrodonta dried leaves extracted with various 
compositions of (IPA) isopropanol and (Aq. EtOH) aqueous ethanol, observed at wavelength 
360 nm. (6-27 min). 
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4.3.2 Forced degradation of 70% extracts of all plants 
The stability of E. tetrodonta, L. glutinosa and M. dealbata 70% ethanol extracts were 
observed by forced degradation studies on fresh plant material collected in May, 2016. Plant 
material extracted in 70% ethanol by sonication, were subjected to high heat (70 °C), UV light, 
acidic and alkaline solutions. Resulting solutions were analysed by UPLC-DAD and data at 
254nm and 360nm were compared to control samples to observe any changes to chemistry.  
The chemistry of E. tetrodonta was conserved when treated with heat and UV light, however 
changes were observed for samples treated with acidic or alkaline solutions at 254 nm and 
360 nm. Figure 20 shows the UPLC chromatograms obtained for all samples at 254nm and 
the acidic and alkaline treated samples at 360nm. The chromatograms indicate that 
compounds eluting between 7-13 min are sensitive to acidic and alkaline conditions as peaks 
present in the control samples are not detected. Furthermore, at 254 nm, an unresolved peak 
eluting from 7-13 min is no longer detected suggesting that these compounds are modified 
under alkaline conditions. In contrast, the peak with retention time 13.9 min is present in all 
samples, however has doubled in intensity in acidic and alkaline treated samples at 254nm 
and 360nm, suggesting this compound can also be modified in acidic and alkaline conditions.  
Much of the chemistry of M. dealbata is conserved between the heat and UV treated samples 
in line with the control, however at 360nm, the peak with a retention time of 20 min, is 
completely degraded in heat, as well as under acidic or alkaline conditions (Figure 21). 
Additionally, a peak observed at 17.3 min at 360 nm, is half as intense in the heat treated 
sample as the control, and is not present at all under alkaline conditions. At 254 nm much of 
the chemistry is degraded under alkaline conditions, however much of the  
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chemistry is conserved with heat, UV and acidic samples in comparison to the control. 
Observable changes can be seen for samples treated under acidic conditions for peaks with 
retention time 14.0 min, which has doubled in intensity compared to the control.  At 254 nm, 
the chemistry observed at retention time 9-14 min is conserved between all L. glutinosa 
samples tested including a major peak at 13.5 min at both 254 nm and 360 nm (Figure 22). 
Additionally, the peak present at 14.5 min is also present in all samples at both wavelengths, 
however in the alkaline treated samples; the intensity is doubled and tripled in comparison
Figure 20 Representative fingerprint chromatogram of E. tetrodonta 70% aq. ethanol extract at 
(A) 254nm and (B) 360nm, having undergone forced degradation by heating, UV light, acidic 
and alkaline conditions. (6-27 min). 
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Figure 21 Representative fingerprint chromatogram of M. dealbata 70% aq. ethanol extract at 
(A) 254nm and (B) 360nm, having undergone forced degradation by heating, UV light, acidic 
and alkaline conditions. (6-27 min). 
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Figure 22 Representative fingerprint chromatogram of L. glutinosa 70% aq. ethanol extract at 
(A) 254nm and (B) 360nm, having undergone forced degradation by heating, UV light, acidic 
and alkaline conditions. (6-27 min.). 
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 to the control sample at 254 nm and 360 nm, respectively. At 360 nm, degradants between 
20-22 min are observed for alkaline samples however at 23 min, the peak has degraded which 
is present in all other samples, including the control. Furthermore, the peak present at 24.5 
min in all samples at 360 nm is half as intense heat and acidic treated samples, suggesting 
that under either of these conditions, this entity is degraded.   
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4.4 Conclusion 
The potential of plants to be successful therapeutics depends upon the extraction of 
biologically relevant chemistry. In this chapter, methods such as activity-guided fractionation, 
extraction solvent comparison and degradation have been chosen to inform YMR members 
about the therapeutic potential of their plants, particularly E. tetrodonta.   
The preliminary phase involved the activity-guided fractionation of the 70% aqueous ethanol 
extracts of E. tetrodonta by column chromatography to elucidate chemistry responsible for 
observed antimicrobial and antifungal activity.  Assessed against microbes S. aureus, S. 
pyogenes, P. aeruginosa and C. albicans, the polar fractions were found to possess 
antimicrobial activity against S. aureus and P. aeruginosa, and the non-polar fractions 
againstS. pyogenes. Interestingly, all fractions of the 70% aq. ethanol extract of E. tetrodonta 
lost their antifungal activity against C. albicans. E. tetrodonta was also used to determine the 
effect of different compositions of water and ethanol and water and isopropanol. Overall it 
was determined that both solvents extracts were comparable and isopropanol may be a 
suitable alternative solvent for use by the YMR members in the extraction of their plant 
material. 
The final method used to study the therapeutic effect of the plants was to determine the 
effects of forced degradation would cause plant extracts. Alkaline and acidic conditions were 
the most detrimental to the ethanoic extracts of the plant material suggesting that after long 
exposure to these conditions, it would be detrimental to the shelf life of the product. 
Additionally, M. dealbata showed to be the most effected by heat, and would be well suited 
for storage in a cool dry place. These studies have provided preliminary data which will 
provide the groundwork for further studies to determine active components. These further 
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studies will ensure that the manufacturing and production of the YMR bush products can 
continue to maintain a consistent and therapeutically favourable product.  
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Chapter 5 Discussion 
___________________________________________________________________________ 
This chapter presents the overall discussion for the thesis, including steps forward. 
  
  
115 
5.1 Discussion 
Respectful and ethical collaboration with Aboriginal and Torres Strait Islanders is a 
fundamental characteristic for community engagement and research. It is becoming ever 
clearer that for the best outcomes for Indigenous people, they should be involved in all 
aspects of research. Increasing the power of Aboriginal and Torres Strait Islanders in decision 
making and benefit sharing ensures that outcomes are relevant to the communities and are 
respondent to their needs.  
Community-university partnerships are an effective collaborative method to ensure that 
research with communities are respectful, honouring the rights of Indigenous people to have 
complete control over their own agendas and affairs. Guided through formal agreements and 
contracts, communities can ensure that their rights are respected at all time.  
This thesis is guided by community-university collaboration with the Yirralka Miyalk 
(Women’s) Rangers (YMR) of the Laynhapuy Homelands, Northern Territory. The 
collaboration was initiated by the Rangers in 2015 who were interested in optimising their 
bush products and understanding more of their bush medicines. The objectives of the 
collaboration are to investigate the medicinal and therapeutic potential of the YMR bush 
products and the three plants- E. tetrodonta, M. dealbata and L. glutinosa, used in their 
manufacture.  
The aims of this thesis were to engage with YMR members to determine the biological and 
chemical investigations which would be relevant to their needs and that of the YMR 
enterprise.  To determine this, semi-structured interviews and focus groups were conducted 
with the YMR members and Laynahapuy Aboriginal Homelands Corporation. The responses 
revealed the YMR members to have great pride in their bush products and a desire to share 
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this with the wider community. They had a desire to help others in their community, and 
through their bush products provide opportunities for the younger generations. The 
participants also discussed the cultural significance of the traditional bush medicines. 
Outcomes of these interviews also included guidance for the future of the collaborative 
partnership and directions for this thesis – to investigate the medicinal and therapeutic value 
of the products and bush medicines for an optimised commercial product.  
Thus, Chapter 3 presented a mixed methods approach for the study of the medicinal value 
of E. tetrodonta, M. dealbata and L. glutinosa. Through a combination of systematic literature 
reviews of the three plants, and investigation of their antimicrobial and anti-inflammatory 
screening, it was found that all three plants possessed medicinal value, as evident through 
published literature, as well as antimicrobial activity against Pseudomonas aeruginosa and 
Candida albicans. Litsea glutinosa also possessed anti-inflammatory activity that was 
significantly different between the two extracts tested.  
Chapter 4 investigation the optimisation of the bush products in three ways- activity-guided 
fractionation and extraction solvent comparison of E. tetrodonta and degradation studies of 
all three plants. Through the interviews in Chapter 2, skin infections were identified one 
illness that the bush products could be therapeutically used for. E. tetrodonta aq. and aq. 
ethanol extracts were the most active antimicrobial extract. To investigate the chemistry 
responsible for this activity, the 70% aq. ethanol extract of E. tetrodonta were separated into 
fractions based on their affinity for various organic solvents, and tested against S. aureus, S. 
pyogenes, P. aeruginosa and C. albicans. The activity was variable between each microbe, 
however this provided preliminary information to the community to determine future steps, 
within the collaboration and for the production of the bush products.  
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Differing compositions of ethanol/water and isopropanol/water were also compared 
through fingerprint chromatography, to determine differences in the chemistry. 
E. tetrodonta was extracted in various combinations from 10% to 95% of ethanol and 
isopropopanol, and it was determined that both solvents were comparable. Chemical 
analysis alone cannot provide definitive evidence and therefore to confirm this, suggestions 
for future work would be to confirm bioactivity of these extracts. 
The final experiment to determine optimisation was the degradation studies of all three 
plants and their 70% ethanol extracts. Plant extracts were exposed to thermal, ultraviolet, 
acidic and alkaline conditions, and their chemistry monitored by UPLC. All samples, in 
comparison to a control untreated plant sample, remained stable under UV treatment, 
however all showed varying numbers of degradants when exposed to acidic or alkaline 
conditions. To overcome this, addition of pH buffering reagents or preservatives to act as 
these, may be a possible option to prevent spoilage of product. 
In conclusion, this Masters of Research project will assist to develop a framework for enabling 
the testing of bush medicines by Aboriginal and Torres Strait Islander communities, 
contributing to a larger organisational strategy to facilitate the support of future Indigenous 
projects. Within a collaborative partnership, this project continues to support YMR members 
and their bush products project through laboratory analysis of their three plants. With the 
knowledge that is gained, it is returned to the community, to continue the PAR cycle, and 
upon reflection and identifying new goals, will continue to build a sustainable and respectful 
partnership.   
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Appx VII. Database search strategies 
Database Search term algorithm 
Eucalyptus tetrodonta 
JSTOR (((("Eucalyptus tetrodonta") OR ("E. tetrodonta")) OR ("Darwin Stringybark")) OR 
("Gadayka")) 
PubMed ((Eucalyptus) AND (tetrodonta)) OR ((E.) AND (tetrodonta)) OR ((Darwin) AND 
(Stringybark)) OR (Gadayka) 
ScienceDirect ({Eucalyptus tetrodonta}) OR ({E. tetrodonta}) OR ({Darwin Stringybark}) OR 
({Gadayka}) 
SciFinder Eucalyptus tetrodonta 
Scopus (ALL(Eucalyptus  PRE/1  tetrodonta) OR ALL(E. PRE/1 tetrodonta) OR 
ALL(Darwin  PRE/1  Stringybark) OR ALL(Gadayka)) 
Melaleuca dealbata 
JSTOR (((((((((("Melaleuca dealbata") OR ("M. dealbata")) OR ("Cloudy Tea Tree")) OR 
("Honey Tree")) OR ("Soapy Tea Tree")) OR ("White Leaf Melaleuca")) OR ("Blue 
Leaved Paperbark")) OR (“Cloudy Teatree”)) OR (“Soapy Teatree”)) OR 
(“Nambarra”)) 
PubMed (Melaleuca AND dealbata) OR (M. AND dealbata) OR (((Cloudy) OR (Soapy)) 
AND (Tea AND Tree)) OR ((Honey) AND Tree) OR (((White leaf) AND 
(Melaleuca)) OR (((Blue leaved) OR (Blue)) AND Paperbark) OR (((Cloudy) OR 
(Soapy)) AND (Teatree)) OR Nambarra 
ScienceDirect ({Melaleuca dealbata}) OR ({M. dealbata}) OR "Cloudy Tea Tree" OR "Honey 
Tree" OR "White Leaf Melaleuca" OR "Soapy Tea Tree" OR "Blue Leaved 
Paperbark" OR "Blue Paperbark" OR "Cloudy Teatree" OR "Soapy Teatree" OR 
({Nambarra}) 
SciFinder Melaleuca dealbata 
Scopus (ALL(Melaleuca PRE/1 dealbata) OR ALL(M. PRE/1 dealbata) OR ALL(Cloudy 
PRE/1 Tea PRE/1 Tree) OR ALL(Honey PRE/1 Tree) OR ALL(White PRE/1 Leaf 
PRE/1 Melaleuca) OR ALL(Soapy PRE/1 Tea PRE/1 Tree) OR ALL(Blue PRE/1 
Leaved PRE/1 Paperbark) OR ALL(Blue PRE/1 Paperbark) OR ALL(Cloudy 
PRE/1 Teatree) OR ALL(Soapy PRE/1 Teatree) OR ALL(Nambarra)) 
Litsea glutinosa 
JSTOR ((("Litsea glutinosa") OR ("L. glutinosa")) OR ("Butjiringaning")) 
PubMed (Litsea AND glutinosa) OR (L. glutinosa) OR Butjiringaning 
ScienceDirect "litsea glutinosa" or "L. glutinosa" or "butjiringaning" 
SciFinder Litsea glutinosa 
Scopus (ALL(Litsea PRE/1 glutinosa) OR ALL(L. PRE/1 glutinosa) OR 
ALL(Butjiringaning)) 
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Appx VIII. Eucalyptus tetrodonta ethnomedicinal uses 
Plant Part Administration Treatment for Preparation method References 
Leaves Chewed Sore throat Unspecified (Barr et al., 1988; Lassak and 
McCarthy, 2011; Smith, 1991b; 
Smith and Wightman, 1990)  
Drink Chest cold Infusion/decoction of crushed 
leaves, in hot or cold water, 
producing a deep purple 
colour. 
(Barr et al., 1988; Lassak and 
McCarthy, 2011) 
Common cold Infused/decoction (Barr et al., 1988; Lassak and 
McCarthy, 2011) 
Headaches and 
Fevers 
Infusion of crushed leaves, to 
form a thick, green liquid 
(Lassak and McCarthy, 2011; 
Webb, 1969; Williams, 2011) 
Poultice Musculoskeletal 
pain 
Heated over a flame and 
applied directly to the affected 
area;  
(Aboriginal Communities of the 
Northern Territory of Australia et 
al., 1993; Barr et al., 1988; 
Lassak and McCarthy, 2011) 
Skin sores Leaves crushed and applied 
directly to affected area 
(Lassak and McCarthy, 2011) 
Wash Fever Infusion (or decoction) of 
crushed leaves, in hot or cold 
water, producing a deep 
purple colour. 
(Barr et al., 1988; Webb, 1969) 
Skin sores Decoction is made of the 
leaves until a red colour 
appears 
YMR Rangers, unpubl. 
Inhalation/ 
topical 
Relieve labour & 
induce lactation 
Placed on fire, woman in 
labour squats over fireplace to 
relieve labour pains; breasts 
over fireplace to increase 
lactation 
Janice Reid cited in Manderson, 
1981  
Young 
leaves 
Chewed Common cold - (Isaacs, 2002) 
Drink 
 
Chest cold Infusion (or decoction) to 
produce a purple liquid 
YMR Rangers, unpubl. 
Common cold Infusion (or decoction) to 
produce a purple liquid 
YMR Rangers, unpubl. 
Headaches and 
Fevers 
Leaves crushed and rubbed 
with hands in water to make 
thick green extract 
(Cribb and Cribb, 1981; Webb, 
1969) 
Poultice Skin sores Crushed and applied directly (Aboriginal Communities of the 
Northern Territory of Australia et 
al., 1993; Barr et al., 1988; 
Isaacs, 2002; Smith, 1991b; 
Smith and Wightman, 1990) 
Young 
leaves 
Wash Scabies Decoction is made of the 
crushed leaves, and the liquid 
applied to the affected area 
(Yunupingu et al., 1994) 
Skin sores Infusion/decoction of crushed 
leaves, in hot or cold water, 
producing a deep purple 
colour. 
(Aboriginal Communities of the 
Northern Territory of Australia et 
al., 1993; Barr et al., 1988; 
Isaacs, 2002; Smith and 
Wightman, 1990) 
Bark Drink general health Decoction (Cribb and Cribb, 1981) 
Poultice Skin sores Crushed and applied directly YMR Rangers, unpubl. 
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Inner bark Drink Common cold Decoction to produce a purple 
liquid 
(Smith and Wightman, 1990) 
   
Diarrhoea Crushed and infused in small 
amount of water 
(Barr et al., 1988; Webb, 1969) 
Pain and post-
birth bleeding, 
promote 
lactation 
Infusion in hot water (Brock and Dunlop, 1993) 
Mouthwash 
 
Mouth sores Infusion/decoction of crushed 
material in cold water 
(Aboriginal Communities of the 
Northern Territory of Australia et 
al., 1993; Isaacs, 2002; Lassak 
and McCarthy, 2011; Smith, 
1991b; Smith and Wightman, 
1990) 
Poultice Skin sores Crushed and applied directly (Isaacs, 2002) 
Wash Scabies Infusion/decoction of crushed 
material in either hot or cold 
water 
(Aboriginal Communities of the 
Northern Territory of Australia et 
al., 1993; Lassak and McCarthy, 
2011; Smith, 1991b; Smith and 
Wightman, 1990) 
Inner bark 
& 
sapwood 
Drink Chest cold Decoction (Aboriginal Communities of the 
Northern Territory of Australia et 
al., 1993) 
Diarrhoea Infusion (Lassak and McCarthy, 2011) 
Mouthwash Mouth sores Infusion of crushed bark and 
sapwood in hot or cold water, 
to produce a reddish-purple 
liquid, filtered 
(Barr et al., 1988) 
Wash Scabies Infusion (Lassak and McCarthy, 2011) 
Skin sores Infusion of crushed bark and 
sapwood in hot or cold water, 
to produce a reddish-purple 
liquid, filtered 
(Barr et al., 1988; Lassak and 
McCarthy, 2011) 
Branches Inhalation/ 
topical 
Post-birth 
bleeding 
Branches are burnt to produce 
smoke 
(Brock and Dunlop, 1993) 
Gum Wash Skin sores Infused, concentrated in 
water, applied directly to 
affected areas 
(Isaacs, 2002) 
Sap Poultice Skin sores - (Locher and Currie, 2010) 
(-) denotes unspecified data  
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Appx IX. Melaleuca dealbata phytochemistry of oil extracts 
(-) denotes unspecified data  
Class Compound Reference 
Sesquiterpenes α-bisabolene (Brophy and Doran, 1996) 
α-bulnesene (Brophy and Doran, 1996) 
α-gurjunene (Brophy and Doran, 1996) 
Alloaromadendrene (Brophy and Doran, 1996) 
Aromadendrene (Brophy and Doran, 1996) 
α-selinene (Brophy and Doran, 1996) 
β-caryophyllene (Brophy et al., 2013; Brophy and Doran, 1996) 
β-selinene (Brophy and Doran, 1996) 
Calacorene (Brophy and Doran, 1996) 
Calamanene (Brophy and Doran, 1996) 
Caryophyllene oxide (Brophy et al., 2013; Brophy and Doran, 1996) 
E,E-farnesol (Brophy and Doran, 1996) 
Globulol (Brophy et al., 2013; Brophy and Doran, 1996) 
Humulene (Brophy and Doran, 1996) 
Palustrol (Brophy and Doran, 1996) 
Spathulenol (Brophy et al., 2013; Brophy and Doran, 1996; 
Yatagai et al., 1998) 
T-cadinol (Brophy and Doran, 1996) 
T-muurolol (Brophy and Doran, 1996) 
Viridiflorene (Brophy and Doran, 1996) 
Viridiflorol (Brophy and Doran, 1996) 
Guaiol (Yatagai et al., 1998) 
Monoterpenes α-pinene (Brophy et al., 2013; Brophy and Doran, 1996; 
Yatagai et al., 1998) 
α-terpineol (Brophy and Doran, 1996) 
β-pinene (Brophy and Doran, 1996; Yatagai et al., 1998) 
E-β-ocimene (Brophy and Doran, 1996) 
Limonene (Brophy and Doran, 1996; Yatagai et al., 1998) 
Terpinen-4-ol (Brophy and Doran, 1996; Yatagai et al., 1998) 
1,8-cineole (Brophy and Doran, 1996) 
p-cymene  (Brophy and Doran, 1996) 
α-phellandrene (Yatagai et al., 1998) 
β-phellandrene (Yatagai et al., 1998) 
Linalool (Yatagai et al., 1998) 
Myrcene (Yatagai et al., 1998) 
Pinocarveol (Yatagai et al., 1998) 
Sabinyl acetate (Yatagai et al., 1998) 
Phenylpropanoid Methyl isoeugenol (Yatagai et al., 1998) 
Methyl eugenol (Yatagai et al., 1998) 
Benzaldehyde Benzaldehyde (Brophy and Doran, 1996) 
Veratraldehyde (Yatagai et al., 1998) 
Ester Methyl cinnamate (Yatagai et al., 1998) 
Steroid Estragol (Yatagai et al., 1998) 
- 
 
Leptospermone (Brophy, 1999) 
2,3-dimethoxy 5-propen-2-yl-phenol (Yatagai et al., 1998) 
Elemicine (Yatagai et al., 1998) 
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Appx X. Litsea glutinosa ethnomedicinal uses 
Plant part Administration Treatment for  Preparation method Location Reference 
Bark Cataplasm Bone fracture Formulation: macerated with 
stems of Euphorbia nivulia, 
stem of Cissus 
quadrangularis, leaf of 
Litsea clarkei, leaf of Sida 
rhombifolia and applied to 
affected area; changed 
every 2-3 days 
Bangladesh (Rahmatullah et al., 
2014) 
Drink Abdominal pain Grate bark, soak in water 
and drink 1-2 cups per day 
Mauritius (Samoisy and 
Mahomoodally, 2015) 
Joint 
inflammation 
Infusion of the bark, drink 
one cup once 
Mauritius (Samoisy and 
Mahomoodally, 2015) 
Nausea and 
vomiting 
Decoction, material strained 
and drunk 
Australia (Lassak and McCarthy, 
2011) 
Drops/wash Infected eyes Juice from crushed leaves 
administered directly  
Australia (Lassak and McCarthy, 
2011) 
Inhalation Nausea and 
vomiting 
Crush leaves and inhale 
vapour 
Australia (Lassak and McCarthy, 
2011) 
Poultice Muscle pain Mixed with water, warmed 
and applied affected area 
India (Singh et al., 2008) 
Skin infection Chewed leaves applied 
directly 
Australia (Lassak and McCarthy, 
2011) 
Wash Aches and pains Decoction Australia (Lassak and McCarthy, 
2011) 
Boils Decoction India (Quattrocchi, 2012) 
Sores and 
scabies 
Decoction Australia (Brock and Dunlop, 
1993) 
- Body pain - India (Quattrocchi, 2012) 
Boils Paste India (Sharma et al., 2014) 
Bone fracture Powder; preparation not 
specified 
India (Quattrocchi, 2012) 
Diarrhea and 
dysentery 
- Australia, 
India 
(Quattrocchi, 2012) 
Skin erosion Mashed and applied to 
affected parts 
China (Li and Xing, 2016) 
Skin infection Paste of bark powder is 
applied to the affected area 
India (Kumar et al., 2012) 
Snake bites Powder; preparation not 
specified 
India (Quattrocchi, 2012) 
Bark gum Emollient Bruises, joint 
inflammation, 
rheumatism, 
skin wounds, 
sprains and 
bruises 
Ground to paste and applied 
directly 
India (Morton, 1990) 
 
- Diarrhea and 
dysentery 
- India (Morton, 1990) 
Berries - Rheumatism Oil extracted from berries Bangladesh (Ghani, 2003) 
Buds, 
young 
leaves and 
sap 
Drink Gastrointestinal 
discomfort 
Combined with water to 
make viscous liquid 
Mauritius (Sussman, 1980) 
Inner bark Chewed Diarrhea and 
dysentery 
- India (Quattrocchi, 2012) 
Stomach ache - India (Quattrocchi, 2012) 
Leaves Drink Constipation Decoction in water and 
strained 
India (Sharkar et al., 2013) 
Gastrointestinal 
discomfort 
Crushed and juice liquid 
drink 
India (Choudhury et al., 
2015a) 
Nausea and 
vomiting 
Decoction (or infusion) of 
material, strained 
Australia (Isaacs, 2002) 
Drops/wash Infected eyes Juice from crushed leaves 
administered directly  
Australia (Melzer and Plumb, 
2007) 
 Emollient Sore muscles - Australia (Brock and Dunlop, 
1993) 
- - India (Morton, 1990) 
Inhalation Chest 
congestion 
Crushed in hands and 
rubbed directly onto chest 
Australia (Yunupingu et al., 1994) 
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Nausea and 
vomiting 
Crushed in hands to 
produce vapours 
Australia (Barr et al., 1988) 
- Aches and pains Decoction applied directly to 
affected areas 
Australia (Cribb and Cribb, 1981) 
Antispasmodic - India (Morton, 1990) 
Boils - India (Choudhury et al., 
2015b) 
Bone fracture - India (Singh et al., 2008) 
Digestive 
discomfort  
Decoction India (Choudhury et al., 
2015b) 
    
Gonorrhoea - India (Das et al., 2013b) 
Nausea and 
vomiting 
- India (Manna and Manna, 
2016) 
Respiratory 
disorders 
Juice from crushed leaves  Bangladesh (Ghani, 2003) 
Skin infection Chewed and applied directly 
to affected areas  
Australia (Cribb and Cribb, 1981; 
Isaacs, 2002) 
Sprains and 
bruises 
- India (Cribb and Cribb, 1981) 
- Decoction of 3 Vepris 
lanceolata leaves, 3 
L.glutinosa leaves, 5g of 
Zingiber officinale- 3 cups 
taken orally per week 
Mauritius (Sreekeesoon and 
Mahomoodally, 2014) 
Leaves and 
bark 
Drink Body pain Decoction Bangladesh (Mohiuddin et al., 2012) 
Boils Decoction Bangladesh (Mohiuddin et al., 2012) 
Diarrhea and 
dysentery 
Decoction; Infusion in water 
for 60-90 min and material 
crushed in water 
Bangladesh (Mohiuddin et al., 2012) 
Skin infection Decoction Bangladesh (Mohiuddin et al., 2012) 
Paste - - Bangladesh (Mohiuddin et al., 2012) 
Rubbing 
medicine 
Aches and pains Decoction, applied directly to 
affected area 
Australia (Brock and Dunlop, 
1993; Isaacs, 2002) 
Leaves and 
bark 
- Boils - China (Kong et al., 2015) 
Diarrhea and 
dysentery 
Demulcent and mild 
astringent 
China (Zheng and Xing, 2009) 
Leaves and 
fruits 
Drink Increase 
physical strength 
Material is crushed and 
resulting juice taken twice 
daily for 1 week 
Bangladesh (Sharkar et al., 2013) 
Leaves and 
roots 
Poultice Skin wounds Poultice with Curcuma longa 
and applied directly to 
affected area 
Mauritius (Nunkoo and 
Mahomoodally, 2012) 
Leaves and 
stems 
Drink Rheumatism Infusion of leaves taken 
orally 
Mauritius (Sreekeesoon and 
Mahomoodally, 2014) 
Leaves, 
branches 
and roots 
Cataplasm Subcutaneous 
injury 
Mashed material China (Zheng and Xing, 2009) 
Young 
leaves 
Salve Boils - Cambodia Martin 1971 cited in 
Morton, 1990 
Roots Poultice Bruises - Bangladesh (Ghani, 2003) 
Skin wounds - Bangladesh (Ghani, 2003) 
Sprains and 
bruises 
- Bangladesh, 
China 
(Ghani, 2003; Zheng 
and Xing, 2009) 
- Diabetes - China (Kong et al., 2015) 
Diarrhea and 
dysentery 
- China (Kong et al., 2015) 
Gastrointestinal 
discomfort 
- China (Kong et al., 2015) 
Joint 
inflammation 
- China (Kong et al., 2015) 
Mumps - China (Kong et al., 2015) 
Seeds - Rheumatism Oil extracted from seeds China (Zheng and Xing, 2009) 
Stem bark Drink Backache Infusion made from 10-15g 
powder, taken at bed time 
for 2–4 days 
India (Shah et al., 2015) 
Eaten Backache Infusion mixed with maize 
flour and ghee, fried and 
eaten 
India (Shah et al., 2015) 
Poultice Leucorrhoea  Mixed with goats milka and 
applied to affected area 
India, 
Bangladesh 
(Khatun et al., 2014) 
Topical Snake  bites Paste India (Quattrocchi, 2012) 
  
138 
- Diarrhea and 
dysentery 
Demulcent and mild 
astringent 
Bangladesh (Ghani, 2003) 
Unspecified - Boils - India (Sharma et al., 2014) 
Bone fracture - India, 
Bangladesh 
(Khatun et al., 2014; 
Vijayagiri and 
Mamidala, 2012) 
Diarrhea and 
dysentery 
- Bangladesh (Khatun et al., 2014) 
Epilepsy - Bangladesh (Khatun et al., 2014) 
Gastrointestinal 
discomfort 
- Australia (Ndi et al., 2016) 
Hook worm 
infestation 
- Bangladesh (Khatun et al., 2014) 
Joint 
inflammation 
- Bangladesh (Khatun et al., 2014) 
Liver disease - Bangladesh (Khatun et al., 2014) 
Muscle pain Liquid preparation Australia (Barr et al., 1988) 
Muscle spasms - Australia (Barr et al., 1988) 
  Osteoporosis - India (Rangrez et al., 2011) 
 - Respiratory 
disorders 
- Bangladesh (Khatun et al., 2014) 
Skin infection Liquid preparation Australia (Barr et al., 1988) 
Skin wounds - India (Panda, 2014; Rout and 
Thatoi, 2009) 
Snake bites Creaming into wounds Sri Lanka,  
Vietnam 
(Dharmadasa et al., 
2016; Duñg and Loi, 
1991) 
(-) denotes unspecified data  
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Appx XI. Litsea glutinosa phytochemistry 
Class Compound Plant part Reference 
Alkaloid Boldine L (Bhakuni et al., 1977b; Ndi et al., 
2016; Tewari et al., 1974) 
(S)-glaucine L (Bhakuni and Jain, 1988) 
Isoboldine L (Collins and CSIRO, 1990; Hart 
et al., 1969; Ndi et al., 2016) 
(S)-isoboldine L (Bhakuni and Jain, 1988) 
(+)-isoboldine - (Tewari et al., 1974) 
Laurelliptine L (Collins and CSIRO, 1990; Hart 
et al., 1969) 
Laurolitsine B (Collins and CSIRO, 1990; Hart 
et al., 1969) 
Laurotetanine L, B (Collins and CSIRO, 1990; 
Lassak and McCarthy, 2011; 
Morton, 1990)  
Liriodenine L (Collins and CSIRO, 1990; Hart 
et al., 1969) 
Litseglutine A L, TW (Yang et al., 2005) 
Litseglutine B L, TW (Yang et al., 2005) 
N-methylactinodaphnine L (Ndi et al., 2016) 
N-methyllaurotetanine L (Ndi et al., 2016) 
Reticuline L, B (Bhakuni et al., 1977a; Collins 
and CSIRO, 1990; Lassak and 
McCarthy, 2011) 
(S)-reticuline L (Bhakuni and Jain, 1988) 
(+)-reticuline  - (Tewari et al., 1974) 
Aldehyde (E)-2-hexenal - (Zhou, 2012) 
Z-9-hexadecenal LD (Qin et al., 2012) 
Tetradecanal LD (Qin et al., 2012) 
Myrtenal FU, FR (Choudhury et al., 1996) 
Alcohol 2-methyl-3-buten-2-ol FU, FR (Choudhury et al., 1996) 
Butenolide (3R,4S,5S)-2-hexadecyl-3-hydroxy-4-
methylbutanolide 
H (Agrawal et al., 2013) 
Litsealactone C H (Agrawal et al., 2013) 
Litsealactone D H (Agrawal et al., 2013) 
Litsealactone G H (Agrawal et al., 2013) 
Diterpenoid Phytol LD, LF, L (Chowdhury et al., 2008; Qin et 
al., 2012; Zhou, 2012)  
Diyne 3-octen-5-yne, 2,7-dimethyl F, L (Chowdhury et al., 2008) 
Ester Benzyl benzoate L (Son et al., 2014) 
Cinnamyl acetate L (Chowdhury et al., 2008) 
Spatozoate B (Ninh et al., 2015) 
Flavonoid glycoside Glutin L, TW (Wang et al., 2010) 
Kaempferol 3-glucoside L (Mohan et al., 1975, 1978) 
Kaempferol 7-glucoside L (Mohan et al., 1975, 1978) 
Kaempferol-3-O-α-L-rhamnoside - (Wang et al., 2008) 
Kaempferol-3-O-β-D-galactoside - (Wang et al., 2008) 
Quercetin-3-rhamnoside L (Mohan et al., 1975, 1978) 
Quercetin-3-O-α-L-arabinoside - (Wang et al., 2008) 
Quercetin-3-O-β-D-rhamnoside - (Wang et al., 2008) 
Pelargonidin 3-glucoside L (Mohan et al., 1975) 
Pelargonidin 5-glucoside L (Mohan et al., 1978) 
Sitosterol β-D-glucopyranoside L, TW (Wang et al., 2010) 
Fatty acid Capric acid S (Kotoky et al., 2007) 
cis-5,8,11,14,17-eicosapentaenoic acid 
methyl ester 
B (Ninh et al., 2015) 
 n-hexadecanoic acid L, F (Chowdhury et al., 2008) 
Lauric acid FU, F, FR, L (Choudhury et al., 1996; 
Chowdhury et al., 2008; Kotoky 
et al., 2007) 
(Z)-9-octadecenamide L (Son et al., 2014) 
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Oleic acid F (Chowdhury et al., 2008) 
Palmitic Acid LD, LF (Qin et al., 2012) 
Tetradecanoic acid LD (Qin et al., 2012; Son et al., 
2014) 
Fatty acid ester Glycerol 1,3-di-(9Z,12Z-
octadecadienoate), 2-hexadecanoate 
B (Ninh et al., 2015) 
Fatty alcohol 1-eicosanol B (Ninh et al., 2015) 
1-heptadecanol B (Ninh et al., 2015) 
(Z)-3-hexen-1-ol - (Zhou, 2012) 
Vomifoliol AP (Xu et al., 2016) 
Flavonoid Epicatechin L, TW (Wang et al., 2010) 
(+)-gallocatechin - (Wang et al., 2008) 
Naringenin L (Mohan et al., 1978) 
Naringin L (Mohan et al., 1975) 
Quercetin L (Mohan et al., 1978) 
Rutin - (Wang et al., 2008) 
Glucopyranoside [(2R,3S)-2,3-dihydro-2-(4-hydroxy-3-
methoxyphenyl)-5-(3-hydroxypropyl)-7-
methoxy-1-benzofuran-3-yl]methyl β-D-
glucopyranoside 
ST (Pan et al., 2010) 
Glycoside (-)-isolariciresinol-5’-methoxy-9’-O-β-D-
xylopyranoside 
ST (Pan et al., 2010) 
(-)-isolariciresinol-9’-O-β-D-xylopyranoside ST (Pan et al., 2010) 
Ketone 1-buten-3-one FU, FR (Choudhury et al., 1996) 
Lignan Glochidioboside ST (Pan et al., 2010) 
(7’R,8S,8’R)-nudiposide ST (Pan et al., 2010) 
Ssioriside ST (Pan et al., 2010) 
Megastigmane  
O-glucopyranosides 
(6R,7E,9R)-9-hydroxy-megastigma-4,7-
dien-3-one 9-O-β-D-glucopyranoside 
L, TW (Wang et al., 2012) 
Alangionoside E L, TW (Wang et al., 2012) 
Apocynoside I L, TW (Wang et al., 2012) 
Apocynoside II L, TW (Wang et al., 2012) 
Blumenol C Glucoside L, TW (Wang et al., 2012) 
Euodionoside A L, TW (Wang et al., 2012) 
Euodionoside F L, TW (Wang et al., 2012) 
Euodionoside G L, TW (Wang et al., 2012) 
Roseoside L, TW (Wang et al., 2012) 
Spinoside A L, TW (Wang et al., 2012) 
Monoterpene Alloocimene L, FR, FU (Choudhury et al., 1996; Son et 
al., 2014) 
Artemisia triene LD, LF (Qin et al., 2012) 
Borneol NA ; FU (Choudhury et al., 1996; Zhou, 
2012) 
Camphene FR, LD, LF, 
FU, L 
(Choudhury et al., 1996; Qin et 
al., 2012; Son et al., 2014) 
1,8-cineole FU, FR (Choudhury et al., 1996; Zhou, 
2012) 
Cyclohexanol, 2-methylene-5-(1-
methylethenyl) 
L (Chowdhury et al., 2008) 
β-damascenone LD (Qin et al., 2012) 
 Eusmoside C H (Agrawal et al., 2013) 
Isoborneol FU, FR (Choudhury et al., 1996) 
Linalool LD, LF, L, FR, 
FU 
(Choudhury et al., 1996; Qin et 
al., 2012; Son et al., 2014) 
 Limonene FR, FU, L, F (Choudhury et al., 1996; 
Chowdhury et al., 2008; Son et 
al., 2014) 
D-limonene LD, LF (Qin et al., 2012) 
Myrcene FR, FU, L, LD, 
LF 
(Choudhury et al., 1996; Qin et 
al., 2012; Son et al., 2014) 
β-myrcene L (Chowdhury et al., 2008) 
6,10,14-trimethylpentadecane-2-one LD, LF (Qin et al., 2012) 
α-Phellandrene LD, LF, L, F (Chowdhury et al., 2008; Qin et 
al., 2012; Son et al., 2014) 
α-pinene FR, FU, LD, 
LF, L 
(Choudhury et al., 1996; Qin et 
al., 2012; Son et al., 2014) 
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β-pinene L, LF, LD, FU, 
FR 
(Choudhury et al., 1996; 
Chowdhury et al., 2008; Qin et 
al., 2012; Son et al., 2014)  
(E, E)-2,6-dimethyl-3,5,7-Octatriene-2-ol L (Son et al., 2014) 
β-ocimene LD, LF (Chowdhury et al., 2008; Qin et 
al., 2012) 
(E)-β-ocimene FR, L, LD, LF, 
FU 
(Choudhury et al., 1996; Qin et 
al., 2012) 
(Z)-β-ocimene FR, FU, L (Choudhury et al., 1996; Son et 
al., 2014) 
Z-ocimene L (Chowdhury et al., 2008) 
Sabinene FU, FR, LD, LF (Choudhury et al., 1996; Qin et 
al., 2012) 
Terpinen-4-ol L, FU (Choudhury et al., 1996; Son et 
al., 2014) 
α-terpinene L (Son et al., 2014) 
g-terpinene LD, LF (Qin et al., 2012) 
γ-terpinene L (Son et al., 2014) 
α-terpineol L, FR, FU (Choudhury et al., 1996; Son et 
al., 2014) 
Terpinolene LD, LF (Qin et al., 2012) 
α-terpinolene L (Son et al., 2014) 
3-thujene LD, LF (Qin et al., 2012) 
α-thujene L, FR, FU (Choudhury et al., 1996; Son et 
al., 2014) 
Monosaccharide Arabinose L (Mahmud et al., 1993) 
Galactose L (Mahmud et al., 1993) 
Xylose L (Mahmud et al., 1993) 
Phenol 2,6-dimethoxyphenol - (Wang et al., 2008) 
2,4-bis(1,1-dimethylethyl)-phenol - (Zhou, 2012) 
Phenolic acid Syringic acid - (Wang et al., 2008) 
Phenylpropene Eugenol L (Son et al., 2014) 
Eugenol acetate L (Son et al., 2014) 
Methyl eugenol L (Son et al., 2014) 
Safrole L (Son et al., 2014) 
Plant sterol Daucosterol AP, B (Ninh et al., 2015; Xu et al., 
2016) 
Sitosterol L, TW (Wang et al., 2010) 
β‐sitosterol B (Haque et al., 2014; Ninh et al., 
2015) 
Stigmasterol B, L, TW (Haque et al., 2014; Wang et al., 
2010) 
Polyphenol 1,2,3,48,5,6,8a-octahydro-4a,8-dimethyl-2-
(1-methylethyl)-naphthalene 
FR, FU (Choudhury et al., 1996) 
Litseaglutinan A ST (Pan et al., 2010) 
(-)-lyoniresinol ST (Pan et al., 2010) 
(7’S,8R,8’S)-lyoniresinol ST (Pan et al., 2010) 
 (7’S,8R,8’R)-4,4’,9-trihydroxy-3’,5-
dimethyl-9’-O-b-d-xylopyranosyl-2,7’-
cyclolignan 
ST (Pan et al., 2010) 
(7’S,8R,8’S)-4,4’,9-trihydroxy-3,3’,5-
trimethoxy-9’-O-b-d-xylopyranosyl-2,7’-
cyclolignan 
ST (Pan et al., 2010) 
Polyphenol amine 1,2-dihydro-6,8 dimethoxy-7-1-(3,5-
dimethoxy-4-hydroxy-phenyl)-N1,N2-bis-[2-
4(hydroxyphenyl)ethyl]-2,3-napthalene 
dicarboxamide 
AP (Xu et al., 2016) 
Polysaccharide Arabinoxylan B, L (Das et al., 2013b; Herath et al., 
1990) 
Galacturonic acid L (Mahmud et al., 1993) 
Sesquiterpene Alloaromadendrene LD, LF (Qin et al., 2012) 
α-amorphene L, LF, LD (Qin et al., 2012; Son et al., 
2014) 
Aromadendrene FR, L (Choudhury et al., 1996) (Son et 
al., 2014) 
(+)-aromadendrene LD, LF (Qin et al., 2012) 
α-bergamotene LD, LF (Qin et al., 2012) 
Bicyclogermacrene LD, LF (Qin et al., 2012) 
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Bulnesol L (Son et al., 2014) 
β-cadinene LD, LF (Qin et al., 2012) 
∆-cadinene LD, LF (Qin et al., 2012) 
δ-cadinene FR, FU (Choudhury et al., 1996) 
γ-cadinene FR (Choudhury et al., 1996) 
α-cadinol L, LD (Qin et al., 2012; Son et al., 
2014) 
T-cadinol L (Chowdhury et al., 2008) 
α-caryophyllene L, FR, FU (Choudhury et al., 1996; Son et 
al., 2014) 
β-caryophyllene L, FU, FR, LD, 
LF 
(Choudhury et al., 1996; Qin et 
al., 2012; Son et al., 2014)   
Caryophyllene F, L (Chowdhury et al., 2008) 
α-caryophyllene LD, LF (Qin et al., 2012; Son et al., 
2014) 
trans-caryophyllene L, ST (Aboriginal Communities of the 
Northern Territory of Australia et 
al., 1993; Barr et al., 1988) 
Caryophyllene oxide LD, LF, L, FR, 
FU 
(Choudhury et al., 1996; Qin et 
al., 2012; Son et al., 2014) 
Diepi-α-cedrene epoxide L (Chowdhury et al., 2008) 
α-copaene FR, FU, L (Choudhury et al., 1996; Son et 
al., 2014) 
β-cubebene L, LD, LF (Qin et al., 2012; Son et al., 
2014) 
curzerene FR (Choudhury et al., 1996) 
β-elemene FU, FR, L (Choudhury et al., 1996; Son et 
al., 2014) 
γ-elemene FU, FR (Choudhury et al., 1996) 
Elemol LD, LF (Qin et al., 2012) 
β-eudesmol LD, LF (Qin et al., 2012) 
Farnesol LD, LF (Qin et al., 2012) 
(E,E)-α-farnesene FU, FR (Choudhury et al., 1996) 
 Germacrene D FR, FU, LD, LF (Choudhury et al., 1996; Qin et 
al., 2012) 
β-guaiene LD, LF (Qin et al., 2012) 
 γ-gurjunene LD, LF (Qin et al., 2012) 
Isocaryophyllene LD, LF (Qin et al., 2012) 
α-muurolene L, F (Chowdhury et al., 2008) 
γ-muurolene LD, LF (Qin et al., 2012) 
Nerolidol LD, LF (Qin et al., 2012) 
Selinene LD, LF (Qin et al., 2012) 
Spathulenol L (Son et al., 2014) 
(-)-spathulenol LD (Qin et al., 2012) 
Thujopsene L (Chowdhury et al., 2008) 
Viridiflorol L (Son et al., 2014) 
(-) data not obtained; (AP) aerial parts; (B) bark; (F) fruit; (FU) unripened fruit; (FR) ripe fruit; (H) heartwood; (L) leaves; 
(LD) dried leaves; (LF) fresh leaves; (ST) stems; (TW) twigs.  
  
 
